<?xml version="1.0" encoding="iso-8859-1"?>
		<rss version="2.0" >
        <channel>
        <title>rellease ID</title>
        <link>https://relleaseid.com/</link>
        <description>situs relleaseID</description>
        <language>en-us</language>
        <pubDate>Wed, 18 Nov 2026 04:39:32 +0700</pubDate>
        <lastBuildDate>Wed, 18 Nov 2026 04:39:32 +0700</lastBuildDate>
        <generator>rellease ID RSS Generator</generator>
        <managingEditor>relleaseid@gmail.com</managingEditor>
        <webMaster>arie.vcr@gmail.com</webMaster>
		<image>
		<url>https://relleaseid.com/icon.gif</url>
		<title>rellease ID</title>
		<link>https://relleaseid.com/</link>
		<description>Fasilitas RSS dari relleaseID</description>
		</image>
<item>
<title>CHAGEE Grows to Eight Asia Pacific Markets with Brunei Entry; Unveils New Rooted in Tea Store Design</title>
<link>https://relleaseid.com/berita-bisnis/CHAGEE-Grows-to-Eight-Asia-Pacific-Markets-with-Brunei-Entry--Unveils-New-Rooted-in-Tea-Store-Design</link>
<description><![CDATA[<img src=https://relleaseid.com/photo/berita/dir112026/1243_CHAGEE-Grows-to-Eight-Asia-Pacific-Markets-with-Brunei-Entry--Unveils-New-Rooted-in-Tea-Store-Design.jpg border=0 hspace=5 align=left width=350 /><div><br></div><div>Source: Tea Explorer Pte Ltd</div><div><br></div><div>In the new design, tea is not just what CHAGEE serves, but what shapes the space</div><div><br></div><div>SINGAPORE - Media OutReach Newswire - 17 November 2026 -&nbsp;<span style="font-size: 14px;">CHAGEE is growing its family in Asia Pacific, opening its first store in Brunei, while launching a new store design rooted in tea, as the global brand marks nine years since its founding in November, 2017.</span></div><div><br></div><div>Growing across Asia Pacific</div><div><br></div><div>Brunei marks CHAGEE&#039;s eighth market in Asia Pacific, with its first two stores slated to open in Kiulap and Madang. Brunei is CHAGEE&#039;s seventh ASEAN market, joining the family of six markets that opened between 2024-2026 in the region&#039;s largest economies.</div><div><br></div><div>Throughout 2026, CHAGEE continues to grow steadily, city by city. In May, Korea welcomed its first CHAGEE store, quickly expanding to 11 stores within 6 months. Malaysia is now home to more than 200 stores, while in Indonesia, CHAGEE has expanded to Surabaya, Bandung, Bali and Semarang, with Yogyakarta opening soon. In Thailand, CHAGEE has also expanded to Chiang Mai, in addition to its Bangkok stronghold. In total, CHAGEE has opened nearly 400 stores outside of Greater China.</div><div><br></div><div>Rooted in tea</div><div><br></div><div>Beyond store building, CHAGEE is giving guests more ways to enjoy tea, starting with its new Rooted in Tea store design, which debuted at Lotte Mall Cheongnyangni in South Korea in October 2026. Inspired by nature and shaped by tea culture, the design pairs earthy tones and natural textures with simple forms drawn from traditional tea pavilions, while versatile seating and modular counters create a space to connect that evolves with guests.</div><div><br></div><div>The anniversary brings more firsts this November: CHAGEE opens its first Philippine flagship, and Singapore becomes the first market to serve CHAGEE gelato outside China.</div><div><br></div><div>"Nine years ago, CHAGEE began with a simple vision: bringing people together with a great cup of tea. Today, every new market, store and cup provides an opportunity for people from all backgrounds to connect," said Brook Fu, Chief Operating Officer, CHAGEE APAC.</div><div><br></div><div>To thank customers, participating markets are celebrating with anniversary drinks, mascot Teadore and Tear & Win.</div><div><br></div><div>About CHAGEE</div><div>CHAGEE is an international tea brand guided by the vision to connect people and cultures through a great cup of tea. Crafted from whole tea leaves with a focus on wellbeing, CHAGEE&#039;s tea blends rich heritage with modern tastes. With over 7,600 stores worldwide as of November 2026, CHAGEE&#039;s APAC HQ is in Singapore, with stores in Malaysia, Thailand, Indonesia, Vietnam, the Philippines, South Korea, and soon Brunei.</div><div><br></div><div>The issuer is solely responsible for the content of this announcement.</div><div><br></div><div>Hashtags: #CHAGEE</div>   ]]></description>
<pubDate>Tue, 17 Nov 2026 20:30:00 +0700</pubDate>
</item>
<item>
<title>Descartes Named the Leading Provider of Cloud-based TMS Solutions in ARC Advisory Group&#039;s Transportation Management Systems Global Report</title>
<link>https://relleaseid.com/berita-bisnis/Descartes-Named-the-Leading-Provider-of-Cloud-based-TMS-Solutions-in-ARC-Advisory-Group--039-s-Transportation-Management-Systems-Global-Report</link>
<description><![CDATA[<img src=https://relleaseid.com/photo/berita/dir112026/1118_Descartes-Named-the-Leading-Provider-of-Cloud-based-TMS-Solutions-in-ARC-Advisory-Group--039-s-Transportation-Management-Systems-Global-Report.jpg border=0 hspace=5 align=left width=350 /><div><br></div><div>ATLANTA and LONDON, Nov. 17, 2026 (GLOBE NEWSWIRE) -- Descartes Systems Group (Nasdaq:DSGX) (TSX:DSG), the global leader in uniting logistics-intensive businesses in commerce, announced it was named the leading transportation management system (TMS) provider in North America in ARC Advisory Group&#039;s Transportation Management Systems Global Market Research (2025 ? 2030) report. Descartes was also named the leading provider of software as a service (SaaS) and cloud-based hosting services for TMS.</div><div><br></div><div>Descartes was noted as the leading TMS provider in the following industries/retail categories:</div><div><br></div><div>Wholesale & Distribution: Characterized by high-frequency shipments, dynamic routing, and integration with warehouse and inventory systems tailored to distribution operations.</div><div>Home Improvement: Technology must support precise delivery scheduling, high-volume distribution and integration with retail and warehouse systems.</div><div>Department & General Merchandise: Efficient store replenishment, real-time delivery tracking, and coordination across multiple transportation modes for high-volume distribution networks.</div><div>Retail</div><div><br></div><div>Descartes was also named among the top TMS providers in the following industries/retail categories:</div><div><br></div><div>Electronics & Electrical</div><div>Transportation & Logistics</div><div>Food & Beverage</div><div>Grocery/Food & Beverage</div><div>Household & Personal Care</div><div>Apparel</div><div><br></div><div>The report cites several new advancements in Descartes&#039; transportation management portfolio supporting domestic and international shipments across truckload, less-than-truckload, parcel, ocean and air modes:</div><div><br></div><div>AI-enabled freight brokerage platform: The October 2026 acquisition of Tai further expanded Descartes&#039; AI-powered transportation management capabilities for freight brokers across truckload, less-than-truckload, drayage and cross-border operations.</div><div>AI agents that take on freight visibility follow-up: Descartes MacroPoint OpsForce is a suite of AI agents designed to automate freight visibility workflows, maintain tracking continuity, collect missing proof-of-delivery documents and reduce manual check calls.</div><div>Auditable, transparent carrier selection processes: Amidst rising regulatory scrutiny, the new AuditLog capability within Descartes MyCarrierPortal helps freight brokers, third party logistics service providers (3PLs) and shippers standardize carrier reviews, management oversight and time-stamped records of carrier-selection decisions.</div><div>Growing global network behind smarter supply chain AI: The Descartes Global Logistics Network (Descartes GLN) combines the world&#039;s largest inter-enterprise supply chain network, 40+ years of real-world logistics data that reflects how supply chains actually operate, and deep domain expertise to ground AI innovation in real-world logistics execution and deliver measurable results.</div><div><br></div><div>"ARC&#039;s latest research recognizes the strength of our cloud-based transportation management solutions and the breadth of customers and industries we serve," said Andrew Wimer, Associate General Manager, Transportation Management at Descartes. "With Descartes, customers can manage freight more efficiently, strengthen carrier relationships and reduce exposure to risk. By expanding our capabilities through innovation and acquisitions, we&#039;re helping customers improve performance, automate routine work and make better-informed decisions across the shipment lifecycle."</div><div><br></div><div>The ARC report presents a comprehensive five-year (2025?2030) global market forecast and detailed analysis of leading TMS and fleet management providers based on extensive primary data and proprietary modeling.</div><div><br></div><div>Learn more about Descartes&#039; transportation management solutions.</div><div><br></div><div>About ARC Advisory Group</div><div><br></div><div>Founded in 1986, ARC Advisory Group is a technology research and advisory firm serving the industrial, energy, infrastructure and supply chain sectors. ARC research combines primary supplier and end-user input, proprietary databases and secondary sources to produce market sizing, supplier market shares, forecasts, trend analysis and strategic guidance. Learn more at www.arcweb.com.</div><div><br></div><div>About Descartes</div><div><br></div><div>Descartes powers more responsive, efficient, secure and sustainable international and domestic supply chains by uniting logistics-intensive businesses on its Global Logistics Network (GLN). Shippers, carriers, and logistics service providers connect and collaborate on the GLN leveraging technology, data and AI to manage last mile deliveries, domestic and international shipments, transportation rating and payment, global trade research, customs compliance and a variety of regulatory processes. Learn more about Descartes at www.descartes.com and connect with us on LinkedIn and X.</div><div><br></div><div>Global Media Contact</div><div>Cara Strohack</div><div>Tel: 226-750-8050</div><div>cstrohack@descartes.com</div><div><br></div><div>Cautionary Statement Regarding Forward-Looking Statements</div><div>This release contains forward-looking information within the meaning of applicable securities laws ("forward-looking statements") that relate to Descartes&#039; transportation management solution offerings and the potential benefits derived therefrom; and other matters. Such forward-looking statements involve known and unknown risks, uncertainties, assumptions and other factors that may cause the actual results, performance achievements or developments to differ materially from those expressed or implied by such forward-looking statements. </div><div><br></div><div>These factors include, but are not limited to, the factors and assumptions discussed under "Certain Factors That May Affect Future Results" in documents filed with the Securities and Exchange Commission, the Ontario Securities Commission and other securities regulatory authorities in Canada including Descartes&#039; most recently filed annual and interim management&#039;s discussion and analysis which are available under Descartes&#039; profile through the EDGAR website at http://www.sec.gov or through the SEDAR+ website at http://www.sedarplus.com/. </div><div><br></div><div>If any such risks occur, they could, among other consequences, materially adversely affect our business, financial condition or results of operations. In that case, the trading price of our common shares could decline, perhaps materially. Readers are cautioned not to place undue reliance upon any such forward-looking statements, which speak only as of the date made. </div><div><br></div><div>Forward-looking statements are provided for the purposes of providing information about management&#039;s current expectations and plans relating to the future. Readers are cautioned that such information may not be appropriate for other purposes. We do not undertake or accept any obligation to publicly update or revise any forward-looking statements to reflect any change in our expectations or any change in events, conditions or circumstances on which any such statement is based, except as required by law.</div><div><br></div><div>Copyright 2026 GlobeNewswire, Inc.</div>   ]]></description>
<pubDate>Tue, 17 Nov 2026 20:26:00 +0700</pubDate>
</item>
<item>
<title>CGTN: Bagaimana Asia Pasifik bisa menjadi makmur melalui keterbukaan, inovasi, dan kerja sama?</title>
<link>https://relleaseid.com/berita-bisnis/CGTN--Bagaimana-Asia-Pasifik-bisa-menjadi-makmur-melalui-keterbukaan--inovasi--dan-kerja-sama-</link>
<description><![CDATA[<img src=https://relleaseid.com/photo/berita/dir112026/1828_CGTN--Bagaimana-Asia-Pasifik-bisa-menjadi-makmur-melalui-keterbukaan--inovasi--dan-kerja-sama-.jpg border=0 hspace=5 align=left width=350 /><div><br></div><div>Menjelang Pertemuan Pemimpin Ekonomi APEC di Shenzhen, CGTN menerbitkan artikel yang menyoroti upaya Tiongkok sebagai tuan rumah APEC 2026 untuk meningkatkan keterbukaan, inovasi, dan kerja sama di tingkat regional. Artikel itu mengulas bagaimana kontribusi nyata Tiongkok turut mempererat hubungan ekonomi, memperluas peluang pembangunan, dan mendorong kemakmuran bersama di Asia Pasifik.</div><div><br></div><div>SHENZHEN, Tiongkok, Nov. 17, 2026 (GLOBE NEWSWIRE) -- Menurut Bea Cukai Shenzhen, nilai impor dan ekspor Shenzhen dengan negara-negara anggota Kerja Sama Ekonomi Asia-Pasifik (APEC) lainnya mencapai 3,23 triliun yuan ($484,2 miliar) dalam tiga kuartal pertama 2026. Angka tersebut naik 40% dibandingkan periode yang sama tahun sebelumnya dan merupakan yang tertinggi di antara kota-kota di Tiongkok daratan.</div><div><br></div><div>Kota ini akan menjadi tuan rumah Pertemuan Pemimpin Ekonomi APEC tahun ini pada tanggal 18?19 November. Ini merupakan ketiga kalinya Tiongkok menjadi tuan rumah pertemuan itu. Kementerian Luar Negeri Tiongkok pada hari Jumat mengumumkan bahwa Presiden Tiongkok Xi Jinping akan memimpin pertemuan itu dan menyampaikan pidatonya. Beliau juga akan menyampaikan pidato utama dalam KTT CEO APEC yang akan digelar di Shenzhen pada tanggal 17-18 November.</div><div><br></div><div>Dengan mengusung tema "Membangun Komunitas Asia Pasifik untuk Mencapai Kemakmuran Bersama," pertemuan APEC tahun ini menetapkan tiga prioritas utama, yaitu keterbukaan, inovasi, dan kerja sama.</div><div><br></div><div>Keterbukaan menciptakan peluang lintas negara</div><div><br></div><div>"Pintu Tiongkok terhadap dunia tidak akan tertutup, tetapi akan semakin terbuka lebar," ujar Presiden Xi Jinping, seraya menegaskan kembali komitmen negaranya untuk menerapkan keterbukaan berstandar tinggi serta menciptakan peluang baru bagi Asia Pasifik dan dunia melalui modernisasi Tiongkok.</div><div><br></div><div>Tiongkok terus memperluas akses pasar, membuka lebih banyak sektor bagi investasi asing, dan memperbaiki lingkungan usahanya. Hubungan perdagangan dan investasi Tiongkok yang semakin erat dengan mitra-mitra regional juga mendukung industri manufaktur lokal, penciptaan lapangan kerja, dan rantai pasok.</div><div><br></div><div>Di Thailand, pabrik BYD di Rayong yang mulai beroperasi pada Juli 2024 memiliki kapasitas produksi sebesar 150.000 kendaraan per tahun. Lebih dari 90% tenaga kerja di pabrik itu berasal dari Thailand. Di Indonesia, SAIC-GM-Wuling (SGMW) telah menciptakan lebih dari 20.000 lapangan kerja langsung maupun tidak langsung bagi tenaga kerja lokal serta bermitra dengan lebih dari 100 pemasok lokal. Hal ini turut mendorong peningkatan dan pengembangan industri otomotif Indonesia.</div><div><br></div><div>Hubungan bisnis itu merupakan bagian dari upaya lebih luas untuk memperkuat integrasi ekonomi regional. Tiongkok terus mendorong penerapan Perjanjian Kemitraan Ekonomi Komprehensif Regional (RCEP) berkualitas tinggi, mengupayakan keanggotaan dalam Perjanjian Komprehensif dan Progresif untuk Kemitraan Trans-Pasifik (CPTPP) serta Perjanjian Kemitraan Ekonomi Digital (DEPA), dan mendukung Kawasan Perdagangan Bebas Asia Pasifik (FTAAP), yang inisiatif pembentukannya memasuki tahun ke-20 pada tahun ini.</div><div><br></div><div>Benjamin Rae, ekonom senior di Kantor Koordinator PBB di Tiongkok, mengatakan bahwa keterbukaan Tiongkok menciptakan peluang bagi mitra regional melalui penguatan jaringan produksi dan akses ke pasar Tiongkok yang terus berkembang. Hal ini juga turut mendorong pergeseran kerja sama regional dari sekadar perdagangan barang menuju penciptaan nilai tambah yang lebih dalam.</div><div><br></div><div>Mewujudkan prioritas melalui kerja sama nyata</div><div><br></div><div>Di tengah ketegangan perdagangan, gangguan rantai pasok, dan lesunya pertumbuhan ekonomi global, Tiongkok telah bekerja sama dengan negara-negara anggota APEC untuk menghasilkan kerja sama konkret berdasarkan ketiga prioritas itu. Sepanjang tahun ini, upaya itu diwujudkan melalui lebih dari 300 pertemuan dan acara.</div><div><br></div><div>Dalam pertemuan para menteri perdagangan di Suzhou pada bulan Mei, negara-negara anggota APEC sepakat untuk mendorong perdagangan tanpa kertas serta pengakuan lintas negara terhadap dokumen elektronik untuk perdagangan. Dialog lanjutan di Dalian mempertemukan perwakilan pemerintah dan pelaku usaha untuk mengatasi hambatan hukum dan teknis dalam penggunaan dokumen elektronik untuk perdagangan. Dalam forum tingkat tinggi APEC tentang AI yang digelar di Chengdu pada bulan Juli, para peserta merilis pernyataan bersama mengenai keamanan AI, penerapan AI yang bertanggung jawab, dan peningkatan kapasitas. Di Shenzhen, para menteri kehutanan APEC pada bulan Juli sepakat untuk memperkuat pengelolaan hutan berkelanjutan dan memberantas pembalakan liar.</div><div><br></div><div>"Semakin ganas gelombang laut, kita harus semakin kompak," ujar Xi Jinping, seraya menyerukan kepada negara-negara anggota APEC untuk mendukung pembangunan yang terbuka, berbagi peluang, serta mendorong globalisasi ekonomi yang bermanfaat secara universal dan inklusif.</div><div><br></div><div>Josef Gregory Mahoney, profesor ilmu politik dan hubungan internasional di East China Normal University, merujuk pada sejarah kawasan Pasifik untuk menekankan pentingnya menjaga hubungan regional agar tetap terbuka. "Di laut ada persaingan, tetapi tidak pernah ada tembok pemisah," ujarnya. "Kemakmuran dibangun dengan melampaui batas-batas, bukan dengan mempertahankannya."</div><div><br></div><div>Profesor itu memperingatkan bahwa konfrontasi antarblok dapat memaksa negara-negara yang memiliki hubungan perdagangan erat untuk berpihak pada blok tertentu sehingga meningkatkan biaya dan mengganggu rantai pasok.</div><div><br></div><div>Negara-negara anggota APEC menyumbang sekitar setengah dari perdagangan global, lebih dari 60% PDB global, dan sekitar 40% total penduduk dunia. Saat para pemimpin APEC bertemu di Shenzhen, keputusan yang mereka ambil akan berdampak jauh melampaui kawasan Asia Pasifik. Keputusan itu akan memengaruhi cara negara-negara menghadapi tantangan global serta mengupayakan kemakmuran bersama melalui keterbukaan, inovasi, dan kerja sama.</div><div><br></div><div>Copyright 2026 GlobeNewswire, Inc.</div>   ]]></description>
<pubDate>Tue, 17 Nov 2026 20:21:00 +0700</pubDate>
</item>
<item>
<title>Valeura Share Buyback Programme</title>
<link>https://relleaseid.com/berita-bisnis/Valeura-Share-Buyback-Programme</link>
<description><![CDATA[<img src=https://relleaseid.com/photo/berita/dir112026/3921_Valeura-Share-Buyback-Programme.jpg border=0 hspace=5 align=left width=350 /><div><br></div><div>SINGAPORE, Nov. 17, 2026 (GLOBE NEWSWIRE) -- Valeura Energy Inc. (TSX:VLE, OTCQX:VLERF) ("Valeura" or the "Company") has received Toronto Stock Exchange ("TSX") approval of the Company&#039;s notice of intention to make a new Normal Course Issuer Bid ("NCIB"). </div><div><br></div><div>The NCIB will commence on 20 November 2026 and end on 19 November 2027, or such earlier date as Valeura may determine or upon completion of purchases pursuant to the NCIB. Under the NCIB, Valeura may purchase up to 6,956,023 of its common shares ("Shares"), representing approximately 10% of the public float of Shares as at 06 November 2026. As at 06 November 2026 there were 106,283,899 Shares outstanding.</div><div><br></div><div>Valeura&#039;s management and board feel it is appropriate to offset natural dilution and see the NCIB as a suitable tool to pursue this goal, while also potentially reducing the total Shares outstanding. This reflects the Company&#039;s belief that the market price of the Shares may not reflect Valeura&#039;s intrinsic value and future prospects. The Company believes the purchase of Shares may represent an appropriate use of Valeura&#039;s financial resources to enhance shareholder value.&nbsp;</div><div><br></div><div>Purchases made pursuant to the NCIB will be made in the open market through the facilities of the TSX and/or through alternative Canadian trading systems and all Shares purchased pursuant to the NCIB will be cancelled. The number of Shares that can be purchased is subject to a daily maximum, subject to certain exceptions, of 106,195 Shares, which is equal to 25% of the average daily trading volume of 424,780 for the Shares on the TSX for the period 01 May 2026 to 31 October 2026. Valeura may also employ an automatic share purchase plan with a designated broker, which will allow for purchases of Shares at pre-determined levels at times when Valeura would not otherwise be active in the market due to applicable regulatory restrictions or internal trading black-out periods.&nbsp;</div><div><br></div><div>This new NCIB follows the Company&#039;s previous normal course issuer bid (the "Expiring NCIB") which commenced on 20 November 2025 and will end on 19 November 2026. Under the Expiring NCIB, the Company received TSX approval to purchase up to 6,298,884 Shares. Valeura did not purchase any shares under the Expiring NCIB but purchased 130,000 options and 685,460 performance and restricted share units under the same time period, that would have resulted in the issuance of new shares when exercised.</div><div><br></div><div>Contact details for the Company&#039;s advisors, covering research analysts and joint brokers, including ATB Cormark Capital Markets, Auctus Advisors LLP, Beacon Securities Limited, Canaccord Genuity Ltd (UK), Research Capital Corporation, Roth Canada Inc., and Stifel Nicolaus Europe Limited, are listed on the Company&#039;s website at www.valeuraenergy.com/investor-information/analysts/.</div><div><br></div><div>About the Company</div><div><br></div><div>Valeura Energy Inc. is a Canadian public company engaged in the exploration, development and production of petroleum and natural gas in Thailand and T?rkiye. The Company is executing a growth-oriented strategy, reinvesting into its producing asset portfolio while deploying capital toward further organic and inorganic growth across Southeast Asia. Valeura is committed to delivering value-accretive growth for all stakeholders, underpinned by high standards of environmental, social and governance responsibility.</div><div><br></div><div>Additional information relating to Valeura is also available on SEDAR+ at www.sedarplus.ca.</div><div><br></div><div>Advisory and Caution Regarding Forward-Looking Information</div><div><br></div><div>Certain information included in this news release constitutes forward-looking information under applicable securities legislation. Such forward-looking information is for the purpose of explaining management&#039;s current expectations and plans relating to the future. Readers are cautioned that reliance on such information may not be appropriate for other purposes, such as making investment decisions. Forward-looking information typically contains statements with words such as "anticipate", "believe", "expect", "plan", "intend", "estimate", "propose", "project", "target" or similar words suggesting future outcomes or statements regarding an outlook. Forward-looking information in this news release includes, but is not limited to: statements pertaining to the NCIB and the expected Share purchases thereunder and the Company&#039;s business objectives.</div><div><br></div><div>Forward-looking information involves significant known and unknown risks and uncertainties. Exploration, appraisal, and development of oil and natural gas reserves and resources are speculative activities and involve a degree of risk. A number of factors could cause actual results to differ materially from those anticipated by the Company including, but not limited to: the ability of management to execute its business plan or realise anticipated benefits from the Farm-in and the Bussabong development, including the risk that actual capital expenditures exceed estimates or that development timelines are delayed; the risk of disruptions from public health emergencies and/or pandemics; competition for specialised equipment and human resources; the Company&#039;s ability to manage growth; the Company&#039;s ability to manage the costs related to inflation; disruption in supply chains; the risk of currency fluctuations; changes in interest rates, oil and gas prices and netbacks; potential changes in joint venture partner strategies and participation in work programmes; uncertainty regarding the contemplated timelines and costs for work programme execution; the risks of disruption to operations and access to worksites; potential changes in laws and regulations, the uncertainty regarding government and other approvals; counterparty risk; the risk that financing may not be available; risks associated with weather delays and natural disasters; geopolitical risks and instability; and the risk associated with international activity. See the Company&#039;s most recent annual information form and MD&A for a detailed discussion of the risk factors.</div><div><br></div><div>The forward-looking information contained in this news release is made as of the date hereof and the Company undertakes no obligation to update publicly or revise any forward-looking information, whether as a result of new information, future events or otherwise, unless required by applicable securities laws. The forward-looking information contained in this news release is expressly qualified by this cautionary statement.</div><div><br></div><div>This news release does not constitute an offer to sell or the solicitation of an offer to buy securities in any jurisdiction, including where such offer would be unlawful. This news release is not for distribution or release, directly or indirectly, in or into the United States, Ireland, the Republic of South Africa or Japan or any other jurisdiction in which its publication or distribution would be unlawful.</div><div><br></div><div>Neither the Toronto Stock Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Toronto Stock Exchange) accepts responsibility for the adequacy or accuracy of this news release.</div><div><br></div><div>This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.</div><div><br></div><div>Copyright 2026 GlobeNewswire, Inc.</div>   ]]></description>
<pubDate>Tue, 17 Nov 2026 20:18:00 +0700</pubDate>
</item>
<item>
<title>AI Boom Faces &#039;Last-Mile&#039; Power Challenge as 78% of Data Center Operators Report Electrical Disruption</title>
<link>https://relleaseid.com/berita-bisnis/AI-Boom-Faces---039-Last-Mile--039--Power-Challenge-as-78--of-Data-Center-Operators-Report-Electrical-Disruption</link>
<description><![CDATA[<img src=https://relleaseid.com/photo/berita/dir112026/6995_AI-Boom-Faces---039-Last-Mile--039--Power-Challenge-as-78--of-Data-Center-Operators-Report-Electrical-Disruption.jpg border=0 hspace=5 align=left width=350 /><div><br></div><div>Fluke Corporation study finds two-thirds of data-center operators are not fully prepared for AI&#039;s growing electrical demands, as power-quality issues and skills shortages threaten expansion</div><div><br></div><div>Everett, Washington, Nov. 17, 2026 (GLOBE NEWSWIRE) -- Fluke Corporation study finds two-thirds of data-center operators are not fully prepared for AI&#039;s growing electrical demands, as power-quality issues and skills shortages threaten expansion</div><div><br></div><div>78 percent experienced electrical or power-system issues contributing to disruption, delays, downtime or serious near-misses in the past year.</div><div>Only 33 percent say their electrical infrastructure is fully ready for higher-density AI workloads.</div><div>34 percent say electrical skills shortages have delayed infrastructure upgrades or new capacity.</div><div>29 percent say power-quality issues have reduced their ability to deploy or operate AI/GPU workloads.</div><div>The global race to build and expand AI data centers could face a major setback, with new research from Fluke Corporation raising questions about whether the infrastructure behind the AI boom can deliver on the industry&#039;s ambitious growth plans. While operators race to secure additional grid capacity, weaknesses in the electrical infrastructure inside data centers are threatening to delay the deployment of new AI workloads and disrupt existing operations.</div><div><br></div><div>Just one in three data center operators (33%) say their existing electrical infrastructure is fully prepared for higher-density AI workloads, while nearly eight in ten (78%) have experienced electrical or power-system issues contributing to disruption, delays, downtime or serious near-misses in the past year.</div><div><br></div><div>At the same time, six in ten (60%) say recruiting qualified electrical technicians has become more difficult, with 34% reporting that skills shortages have delayed infrastructure upgrades or new capacity.</div><div><br></div><div>Together, the findings suggest that the challenge for the industry is no longer simply securing power from the grid, but ensuring data centers have the infrastructure and expertise to turn that power into reliable computing capacity.</div><div><br></div><div>Commenting on the findings, Parker Burke, President of Fluke Corporation, said: "The industry has spent years asking where the power will come from. But our findings show that the focus should also be on how effectively data centers can use the power they already have. As AI drives unprecedented demand for computing capacity, the electrical infrastructure inside data centers is becoming a critical bottleneck. Without addressing this last-mile challenge, the industry risks having the power to expand, but not the infrastructure to deliver."</div><div><br></div><div>The consequences are already being felt. More than one in four data center operators (29%) say power-quality issues have reduced their ability to deploy or operate high-density AI or GPU workloads, while 29% report that electrical problems are only identified after performance or equipment failure, or downtime, has occurred.</div><div><br></div><div>Limited visibility into critical electrical systems may be adding to the challenge. Fewer than half of operators (45%) report real-time visibility across those systems, potentially affecting their ability to identify and address problems before they impact operations.</div><div><br></div><div>The internal infrastructure challenges identified by Fluke come alongside wider constraints on electricity supply. Three-quarters of data center operators (76%) say access to sufficient power and grid capacity is moderately or severely limiting their ability to expand, while operators report an average 12-month wait to secure additional grid connection or power capacity for AI and GPU-related expansion.</div><div><br></div><div>While securing additional electricity remains a major challenge, the findings highlight the importance of ensuring that existing electrical infrastructure can reliably support growing power demands.</div><div><br></div><div>Parker Burke continued: "Grid constraints are largely outside an operator&#039;s control. What is within their control is how effectively they monitor, maintain and manage the electrical infrastructure they already have. Greater visibility into electrical systems and a proactive approach to maintenance will be increasingly important as operators look to maximize existing capacity, reduce disruption and support growing AI demand."</div><div><br></div><div>About the survey</div><div><br></div><div>The study, commissioned by Fluke on behalf of Censuswide, surveyed 1,300 data-center industry operators and professionals across six countries, namely the US, UK, Germany, France, India and the Kingdom of Saudi Arabia to understand the power, infrastructure and workforce challenges facing the industry as AI demand accelerates. Find out more here.</div><div><br></div><div>About Censuswide</div><div>Censuswide is an international market research consultancy headquartered in London, with offices in New York, Dubai, Bristol, and Glasgow. Our research supports insights, communication, PR and marketing teams across consumer, B2B/Corporate and Healthcare sectors. Find out more here: https://censuswide.com/</div><div><br></div><div>About Fluke</div><div>Founded in 1948, Fluke Corporation is the world leader in compact, professional electronic test tools and software for measuring and condition monitoring. Fluke customers are technicians, engineers, electricians, maintenance managers, and metrologists who install, troubleshoot, and maintain industrial, electrical, and electronic equipment and calibration processes. FLUKE is a registered trademark of Fluke Corporation. For more information, visit the Fluke website.</div><div><br></div><div>###</div><div><br></div><div>FLUKE is a registered trademark of Fluke Corporation. For more information, visit the Fluke website.</div><div><br></div><div>For more information:</div><div><br></div><div>US:</div><div>Dave Smith</div><div>Fluke Corporation</div><div>dave.smith@fluke.com</div><div>EMEAI:</div><div>Olivia Kline</div><div>Fluke Corporation</div><div>olivia.kline@fluke.com</div><div><br></div><div>Q: What are the biggest electrical infrastructure challenges facing AI data centers?</div><div><br></div><div>A: AI data centers face growing challenges around electrical capacity, power quality, infrastructure reliability and access to skilled electrical technicians. As AI workloads increase power density, operators must ensure that existing electrical systems can safely and reliably support higher demand. Fluke research found that only 33% of data center operators consider their electrical infrastructure fully prepared for higher-density AI workloads.</div><div><br></div><div>Q: How does poor power quality affect AI data center performance?</div><div><br></div><div>A: Poor power quality can cause equipment malfunctions, overheating, unexpected shutdowns and downtime. Issues such as voltage fluctuations, harmonics and electrical disturbances can affect the reliability of critical data center systems. Fluke research found that 29% of operators say power-quality issues have reduced their ability to deploy or operate high-density AI or GPU workloads.</div><div><br></div><div>Q: How can data centers improve electrical reliability and reduce downtime?</div><div><br></div><div>A: Data center operators can improve electrical reliability through regular electrical testing, power-quality monitoring, thermal inspections and preventive maintenance. Identifying voltage disturbances, overloaded circuits, overheating components and other potential faults before they affect operations can help reduce the risk of unplanned downtime and support infrastructure readiness.</div><div><br></div><div>Q: What electrical testing and monitoring solutions does Fluke offer for data centers?</div><div><br></div><div>A: Fluke provides electrical testing and measurement tools, power-quality analyzers, thermal imaging cameras and condition-monitoring solutions for data center environments. These technologies help electrical technicians assess infrastructure performance, troubleshoot faults, monitor power quality and support maintenance programs designed to improve the reliability of critical systems.</div><div><br></div><div>Q: How can data center operators address electrical skills shortages?</div><div><br></div><div>A: Data center operators can help reduce the impact of electrical skills shortages by investing in technician training, standardized testing procedures and diagnostic tools that make electrical troubleshooting more efficient. Fluke provides testing and measurement technologies that help teams identify electrical issues, assess system performance and make informed maintenance decisions as AI infrastructure becomes more complex.</div><div><br></div><div>Copyright 2026 GlobeNewswire, Inc.</div>   ]]></description>
<pubDate>Tue, 17 Nov 2026 20:13:00 +0700</pubDate>
</item>
<item>
<title>Digital Realty Innovation Lab (DRIL) Launches in Singapore, Enabling Asia Pacific Enterprises to Validate and Scale AI-Ready Infrastructure</title>
<link>https://relleaseid.com/berita-bisnis/Digital-Realty-Innovation-Lab--DRIL--Launches-in-Singapore--Enabling-Asia-Pacific-Enterprises-to-Validate-and-Scale-AI-Ready-Infrastructure</link>
<description><![CDATA[<img src=https://relleaseid.com/photo/berita/dir112026/7584_Digital-Realty-Innovation-Lab--DRIL--Launches-in-Singapore--Enabling-Asia-Pacific-Enterprises-to-Validate-and-Scale-AI-Ready-Infrastructure.jpg border=0 hspace=5 align=left width=350 /><div><br></div><div>SINGAPORE, Nov. 17, 2026 (GLOBE NEWSWIRE) -- Digital Realty (NYSE: DLR), the world&#039;s largest cloud- and carrier-neutral data center platform, today announced the opening of the Digital Realty Innovation Lab (DRIL) in Singapore. </div><div><br></div><div>The facility provides enterprises across Asia Pacific with a real-world colocation environment inside a live data center to test, validate, and optimize integrated, multi-vendor AI infrastructure solutions before deploying at scale.</div><div><br></div><div>The launch builds on established DRIL locations in Northern Virginia, Tokyo, London, and most recently, S?o Paulo. Located at Digital Realty&#039;s SIN11 facility in Singapore, the DRIL will help enterprises in the region prepare their digital infrastructure for AI deployment, addressing growing demand for AI-ready infrastructure in Singapore and key Asia Pacific markets.</div><div><br></div><div><span style="font-size: 14px;">Located at Digital Realty&#039;s SIN11 facility in Singapore, the Digital Realty Innovation Lab will help enterprises in the region prepare their digital infrastructure for AI deployment.</span></div><div><br></div><div>The milestone was commemorated at a ceremony graced by Ms Aileen Chia, Deputy Chief Executive Officer, Infocomm Media Development Authority (IMDA)&#8203;, Mr. Herman Loh, Co-Head, Digital Industry Singapore, Singapore Economic Development Board (EDB) and Ms. Cindy Koh, Group Director, Green Growth, JTC Corporation (JTC), alongside Digital Realty leadership including Chris Sharp, Chief Technology Officer, Digital Realty, Serene Nah, Managing Director and Head of Asia Pacific, Digital Realty and Govind Choudhary, General Manager for Southeast Asia and India, Digital Realty.</div><div><br></div><div>Singapore&#039;s DRIL brings together high-density infrastructure, advanced cooling, resilient connectivity, and technologies from solution partners across the infrastructure stack in a live data center environment, providing enterprises with a practical setting to explore how different components work together and identify the right architecture for their needs. This integrated, hands-on approach helps customers determine how the complete solution works together before they scale, helping reduce integration risk and accelerate the path to deployment.</div><div><br></div><div>According to Digital Realty&#039;s 2026 Global Data Insights Survey (GDIS), 40% of IT decision-makers now identify lack of specialized infrastructure as the primary constraint on AI initiatives, more than a fourfold increase from just 9% in 2024. In Singapore, that figure rises to 50%. In addition, nearly six in ten (59%) of organizations across Asia Pacific plan to increase AI spending by more than 25% in 2026.</div><div><br></div><div>"Enterprises deploying AI want to understand how different components and technologies can perform together before committing to infrastructure at scale," said Chris Sharp, Chief Technology Officer, Digital Realty. "The DRIL will provide a production-grade testing environment where customers can work with leading technology partners and our engineering teams to validate AI, high-performance computing and hybrid cloud architectures under real-world conditions. By testing performance, fit, and readiness before deployment, enterprises globally and across Asia Pacific will be able to scale with confidence and achieve more impactful outcomes with AI."</div><div><br></div><div>"Asia Pacific&#039;s ability to realize its AI ambitions depends on how effectively enterprises can prepare their infrastructure for deployment, taking into account the region&#039;s diverse needs and conditions," said Serene Nah, Managing Director and Head of Asia Pacific at Digital Realty. "Singapore&#039;s strong regional connectivity makes it a strategic home for the DRIL, where enterprises in the rest of Asia Pacific can test their solutions with our partners in real time before deploying at scale. Together with our planned data center facility on Jurong Island, the DRIL will help customers in Singapore and across the region move from concept to confidence."</div><div><br></div><div>Key design features of DRIL include:</div><div><br></div><div>High-Density AI Testing - Liquid-cooled racks supporting cabinet densities of 150 kilowatts (kW) and above, with headroom to go higher as the industry evolves.</div><div>Advanced Cooling Capabilities - High-efficiency chilled-water cooling, containment system and both liquid-to-liquid and liquid-to-air cooling configurations enable customers to explore different approaches to managing the thermal demands of AI infrastructure.</div><div>Resilient Infrastructure - A distributed redundant design and parallel uninterruptible power supply (UPS) architecture provide the high availability and operational resilience needed to evaluate infrastructure under real-world data center conditions.</div><div>Flexible Connectivity - Dual, diverse fiber entry paths and a carrier-neutral design provide access to multiple carriers, cloud, and connectivity options, supporting enterprises connecting from markets across the region.</div><div>Integrated Monitoring and Security - Integrated building management system (BMS) and electrical power monitoring system (EPMS) capabilities, alongside multi-layer physical, network and operational security, provide visibility and control across the lab environment.</div><div><br></div><div>The DRIL builds on Digital Realty&#039;s long-term investment in Singapore. In August 2026, the company was selected under Singapore&#039;s second Data Center - Call for Application (DC-CFA2), with a provisional allocation of 50 megawatts (MW) to develop a new AI-ready data center at JTC&#039;s low-carbon data center park on Jurong Island. Digital Realty is also investing in workforce and talent development through the Institute of Technical Education&#039;s Work-Study Diploma and a Digital AI Open House for students from the National University of Singapore&#039;s Tembusu College and the Master of Science in Safety, Health and Environmental Technology (MSc SHE) program. Digital Realty will continue expanding its global network of DRIL locations, with a site in Johannesburg planned for 2027.</div><div><br></div><div>Partner Quotes</div><div><br></div><div>The DRIL is where enterprises can see leading partner platforms perform under real-world conditions so they can prove their ecosystem works together before they scale it, supported by unified facility-to-stack expertise.</div><div><br></div><div>"Enterprises are looking to unlock the value of AI using their own data, while ensuring the underlying infrastructure delivers the performance, security, and reliability they need. With HPE Private Cloud AI running at the DRIL in Singapore, customers can experience and validate an end-to-end private AI environment on Digital Realty&#039;s infrastructure under real-world data center conditions before moving to production. This gives organizations a practical pathway to accelerate AI adoption, build confidence in their deployments and reduce implementation risks across the region," said Khai Peng Loh, Vice President and Managing Director, Singapore and Southeast Asia, HPE.</div><div><br></div><div>"An AI cluster&#039;s performance depends on its connectivity. Our advanced structured cabling and fiber infrastructure at the Singapore DRIL enables partners to rigorously validate high-bandwidth, low-latency links across compute, storage, and the Digital Realty ecosystem?so they can test the same network design they plan to deploy," said Rocky Colapietro, General Manager, CommScope Data Center Solutions.</div><div><br></div><div>"AI only delivers when the network keeps pace with the compute, and customers want to see that before they build. Bringing Cisco&#039;s networking into the DRIL in Singapore gives customers a place to validate how compute, storage and connectivity perform together on Digital Realty infrastructure, under real-world conditions. For organizations across Southeast Asia, that means a faster, more confident path from pilot to production," said Kevin Wollenweber, Senior Vice President and General Manager, Data Center and Internet Infrastructure, Cisco.</div><div><br></div><div>"High-density AI is changing what data centers need to deliver, particularly in how heat is managed from chip to chiller. By bringing Motivair by Schneider Electric liquid cooling technologies into the Digital Realty Innovation Lab in Singapore, we are giving customers and partners an environment to test and validate liquid-cooled infrastructure before moving to production. This kind of validation will be critical to scaling AI infrastructure efficiently and with confidence," said Ivy Xin, Vice President, East Asia, Secure Power and Data Center, Schneider Electric.</div><div><br></div><div>"Distributed AI and real-time applications depend on the network as much as the compute. Bringing Zenlayer&#039;s edge connectivity into the DRIL in Singapore lets customers test how their workloads move across Asia and beyond on Digital Realty&#039;s interconnected infrastructure, before they scale. Validating that path end to end turns a regional deployment plan into one customers can rely on," said Ashlee Yang, Vice President of Partnership & Alliance, Zenlayer.</div><div><br></div><div>"Customers are under pressure to deploy dense compute quickly, and they need evidence rather than assumptions. Our partnership with Digital Realty brings Superliq&#039;s dielectric DLC cold plates to the DRIL in Singapore, with integrated cold plate and immersion solutions to follow. Using Digital Realty&#039;s power, cooling and interconnection, customers can see how the solution performs under real-world data center conditions and plan their deployments with confidence," said TQ Chen, Chief Executive Officer, Superliq.</div><div><br></div><div>"Every validated solution starts with a physical foundation that is ready for the load. Our cabinets, power distribution and containment give the DRIL in Singapore a consistent, high-density-ready platform, so partners can focus on integrating and validating their solutions with Digital Realty rather than on the rack. That consistency matters when customers want results they can repeat at scale," said Vincent Lee, Regional Sales Manager, Southeast Asia, Chatsworth Products (CPI).</div><div><br></div><div>"Liquid cooling performance depends as much on effective fluid management as it does on the hardware. Through Ecolab&#039;s support of the Digital Realty Innovation Lab in Singapore, we can help customers and partners validate water and coolant management strategies for liquid-cooled deployments, building reliability, operational performance and resource efficiency into data center infrastructure from the start," said Ram Nagarajan, Vice President and General Manager, Global High Tech, Ecolab Southeast Asia.</div><div><br></div><div>Enterprises in Singapore and across Asia Pacific can experience the DRIL by engaging their Digital Realty account manager. For more information, visit https://www.digitalrealty.com/expertise/digital-realty-innovation-lab.</div><div><br></div><div>About Digital Realty</div><div>Digital Realty brings companies and data together by delivering the full spectrum of data center, colocation, and interconnection solutions. PlatformDIGITAL, the company&#039;s global data center platform, provides customers with a secure data meeting place and a proven Pervasive Datacenter Architecture (PDx) solution methodology for powering innovation, from cloud and digital transformation to emerging technologies like artificial intelligence (AI), and efficiently managing Data Gravity challenges. Digital Realty gives its customers access to the connected data communities that matter to them with a global data center footprint of 300+ facilities in 55+ metros across 30+ countries on six continents. To learn more about Digital Realty, please visit digitalrealty.com or follow us on LinkedIn and X.</div><div><br></div><div>Safe Harbor Statement&nbsp;</div><div>This press release contains forward-looking statements which are based on current expectations, forecasts and assumptions that involve risks and uncertainties that could cause actual outcomes and results to differ materially, including statements related to the company&#039;s partnerships and expected benefits, expected completion dates, emerging technologies, artificial intelligence, customer demand and the company&#039;s strategy. For a list and description of risks and uncertainties, see the reports and other filings by the company with the U.S. Securities and Exchange Commission. The company disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.</div><div><br></div><div>Copyright 2026 GlobeNewswire, Inc.</div>   ]]></description>
<pubDate>Tue, 17 Nov 2026 20:05:00 +0700</pubDate>
</item>
<item>
<title>Space42 Memulai Produksi Telepon Pintar Satelit ThurayaTwo Bersama Asia Pacific Satellite Inc. Korea Selatan</title>
<link>https://relleaseid.com/berita-bisnis/Space42-Memulai-Produksi-Telepon-Pintar-Satelit-ThurayaTwo-Bersama-Asia-Pacific-Satellite-Inc--Korea-Selatan</link>
<description><![CDATA[<img src=https://relleaseid.com/photo/berita/dir112026/4292_Space42-Memulai-Produksi-Telepon-Pintar-Satelit-ThurayaTwo-Bersama-Asia-Pacific-Satellite-Inc--Korea-Selatan.jpg border=0 hspace=5 align=left width=350 /><div><br></div><div>Didukung oleh jaringan satelit Thuraya-4, ThurayaTwo dirancang untuk menyediakan layanan data dan panggilan VoIP (Voice over Internet Protocol) melalui aplikasi pada telepon pintar&nbsp;</div><div>Perangkat ini ditargetkan mampu menghadirkan kecepatan transmisi data tertinggi di antara telepon satelit berbasis GEO, dengan kecepatan data hingga 120 kbps</div><div>Versi komersial dan pemerintah dijadwalkan akan tersedia di pasar UEA pada kuartal IV 2027</div><div><br></div><div>ABU DHABI, Uni Emirat Arab, Nov. 17, 2026 (GLOBE NEWSWIRE) -- Space42 (ADX: SPACE42), perusahaan teknologi antariksa (SpaceTech) berteknologi AI yang berbasis di Uni Emirat Arab (UEA), hari ini mengumumkan dimulainya produksi ThurayaTwo, telepon pintar satelit generasi mendatangnya untuk layanan data, bersama Asia Pacific Satellite Inc. (APSI) Korea Selatan.</div><div><br></div><div> ThurayaTwo akan menggabungkan konektivitas melalui jaringan satelit geostasioner Space42 dengan akses ke layanan jaringan terestrial 4G dan 5G. Jaringan satelit itu menawarkan kecepatan data hingga 120 kbps. ThurayaTwo dijadwalkan memasuki pasar Uni Emirat Arab (UEA) pada kuartal IV 2027. </div><div><br></div><div>Perangkat ini dirancang untuk mendukung kebutuhan individu dan organisasi di wilayah dengan infrastruktur jaringan seluler terestrial yang tidak dapat diandalkan. Dukungan itu berupa layanan data dan panggilan suara melalui aplikasi telepon pintar.</div><div><br></div><div>Ali Al Hashmi, CEO Unit Bisnis Space Services di Space42, mengatakan: "ThurayaTwo mendorong upaya kami untuk mengintegrasikan konektivitas satelit secara lancar ke dalam komunikasi sehari-hari. Dengan menggabungkan layanan data satelit serta layanan 4G dan 5G dalam satu perangkat, sekaligus menawarkan kecepatan data tertinggi di kategori produknya, kami ingin membantu individu dan organisasi agar tetap terhubung. Upaya ini mewujudkan strategi Jaringan Non-Terestrial kami dalam bentuk produk yang mudah diakses oleh masyarakat dan perusahaan, sekaligus mendukung ambisi kami untuk menjadikan konektivitas sebagai hak asasi manusia."</div><div><br></div><div>Dr. Sunghee Lee, CEO APSI mengatakan: "Kontrak ini memiliki arti penting karena didukung oleh keahlian kami yang telah terbangun selama bertahun-tahun di bidang terminal komunikasi satelit serta pengalaman kami dalam mengembangkan dan memproduksi Thuraya One secara massal untuk mendorong pengembangan produk generasi berikutnya. Berbekal model untuk kebutuhan komersial dan pemerintah, kami akan terus memperluas kehadiran kami di pasar global untuk layanan komunikasi yang sangat penting bagi keberlangsungan misi, yang membutuhkan konektivitas yang dapat diandalkan dan sistem keamanan tangguh."</div><div><br></div><div>Satu telepon, dua versi</div><div><br></div><div>ThurayaTwo akan tersedia dalam dua varian. Versi komersial dirancang untuk memungkinkan bisnis, tim lapangan, dan pengguna individu mengakses berbagai saluran komunikasi multimedia melalui layanan data satelit di wilayah terpencil. Konfigurasi SIM gandanya dirancang agar pengguna dapat beralih antara layanan satelit dan seluler pada satu perangkat.</div><div><br></div><div>Versi untuk pemerintah akan digunakan oleh tim yang menangani informasi sensitif atau beroperasi dalam situasi berisiko tinggi. Perangkat ini dilengkapi fitur keamanan yang dirancang untuk mendeteksi upaya modifikasi fisik yang tidak sah, memverifikasi integritas telepon saat dinyalakan, serta melindungi aplikasi dan data dari akses tidak sah.</div><div><br></div><div>Kedua versi itu diperkirakan akan memiliki fitur berikut:</div><div><br></div><div>Layar AMOLED 6,67 inci</div><div>Kamera belakang 50 MP dengan lensa ultra-wide 13 MP, serta kamera depan 32 MP</div><div>Sensor gerak, navigasi, kedekatan, dan biometrik</div><div>Baterai yang dapat dilepas dengan kapasitas minimal 4.500 mAh</div><div>Ketahanan terhadap debu dan air dengan rating IP67</div><div><br></div><div>Melanjutkan kemitraan dan teknologi yang telah terbangun</div><div><br></div><div>ThurayaTwo melanjutkan fondasi teknologi Thuraya One, yang menggabungkan telepon pintar berbasis Android dengan layanan panggilan suara dan pesan melalui satelit. Model terbaru ini akan menawarkan kecepatan transmisi data tertinggi di antara telepon satelit berbasis orbit geostasioner (GEO), sekaligus memperluas layanan konektivitas yang tersedia melalui telepon pintar Thuraya.</div><div><br></div><div>Hubungan APSI dengan Thuraya dimulai pada tahun 2003 melalui kesepakatan untuk mengembangkan dan memproduksi perangkat komunikasi seluler satelit. Sejak saat itu, APSI telah mendukung beberapa generasi perangkat terminal Thuraya, termasuk Thuraya One.</div><div><br></div><div>ThurayaTwo akan memperluas portofolio produk yang didukung oleh Thuraya-4, salah satu satelit komunikasi seluler terbesar dan tercanggih yang berada di orbit. Thuraya-4 menyediakan konektivitas yang aman di lebih dari 160 negara di Eropa, Afrika, Asia Tengah, dan Timur Tengah.</div><div><br></div><div>Tentang Space42</div><div><br></div><div>Space42 (ADX: SPACE42) adalah perusahaan teknologi antariksa (SpaceTech) berteknologi AI yang berbasis di UEA dan memiliki jangkauan global. Perusahaan ini mengintegrasikan komunikasi satelit dan intelijen geospasial untuk memberikan pemahaman tentang Bumi melalui pengamatan dari antariksa. </div><div><br></div><div>Perusahaan ini beroperasi melalui dua unit bisnis. Space Services mengoperasikan armada satelit geostasioner, termasuk jaringan seluler Thuraya, untuk menyediakan konektivitas yang aman di darat, laut, dan udara di lebih dari 120 negara. Smart Solutions mengoperasikan konstelasi satelit radar apertur sintetis di orbit Bumi rendah yang mencakup 90% populasi dunia. </div><div><br></div><div>Unit bisnis ini menggunakan AI untuk mengolah citra tersebut menjadi informasi yang dapat ditindaklanjuti. Space42 melayani pemerintah dan perusahaan di berbagai sektor, termasuk pertahanan dan keamanan, energi, pelestarian lingkungan, serta mobilitas otonom. Pemegang saham utamanya mencakup G42, Mubadala, dan International Holding Company (IHC).</div><div><br></div><div>Untuk informasi selengkapnya, kunjungi: www.space42.ai; ikuti kami di LinkedIn: Space42</div><div><br></div><div>Tentang APSI</div><div><br></div><div>APSI (KOSDAQ: 211270) adalah perusahaan teknologi antariksa dan satelit asal Korea Selatan yang didirikan pada tahun 2000 dan merayakan hari jadinya yang ke-26 tahun ini. Perusahaan ini bergerak di bidang pengembangan serta produksi terminal komunikasi satelit dan sistem satelit. Dengan memanfaatkan teknologi yang telah teruji dan pengalaman bisnis global di bidang komunikasi satelit, AP Satellite telah memperluas kemampuannya hingga mencakup platform satelit, muatan satelit, dan perangkat elektronik antariksa yang sangat penting bagi keberlangsungan misi.</div><div><br></div><div>APSI beroperasi melalui dua unit bisnis utama yaitu Komunikasi Satelit (Satellite Communications) dan Sistem Satelit (Satellite Systems). Unit bisnis Komunikasi Satelit mengembangkan dan menyediakan terminal komunikasi satelit bergerak serta teknologi komunikasi generasi terbaru yang mengintegrasikan jaringan terestrial dan satelit. Unit bisnis Sistem Satelit menyediakan kemampuan menyeluruh yang mencakup desain, produksi, perakitan, integrasi, dan pengujian platform satelit, muatan satelit, serta peralatan elektronik utama.</div><div><br></div><div>APSI bergabung dengan CONTEC Space Group pada tahun 2024. Dengan menggabungkan kemampuan Grup dalam pengoperasian satelit, infrastruktur stasiun bumi, dan pengolahan data citra satelit dengan keahlian APSI dalam pengembangan serta produksi satelit dan terminal komunikasi, Grup telah membangun rantai nilai industri antariksa yang terintegrasi, mencakup produksi, pengoperasian, hingga pemanfaatan data satelit. </div><div><br></div><div>Melalui Pusat Perakitan, Integrasi, dan Pengujian (Assembly, Integration and Test/AIT) khusus miliknya, APSI terus memperkuat kemampuannya dalam perakitan, integrasi, pengujian, dan verifikasi satelit, sekaligus memperluas kemitraan dan peluang bisnis dengan lembaga pemerintah serta perusahaan global.</div><div><br></div><div>Pemberitahuan Hukum dan Pernyataan Kehati-hatian terkait Informasi Berwawasan ke Depan</div><div>Pengumuman ini mungkin memuat pernyataan berwawasan ke depan berdasarkan ekspektasi dan asumsi saat ini tentang peristiwa di masa mendatang. Pernyataan-pernyataan ini, yang ditandai dengan istilah seperti "memperkirakan", "akan", atau istilah serupa, mengandung risiko dan ketidakpastian sehingga mungkin terbukti tidak akurat. </div><div><br></div><div>Pernyataan ini mencerminkan informasi yang tersedia hingga tanggal penyusunan dokumen ini, dan perusahaan secara tegas menolak segala kewajiban untuk memperbaruinya. Tidak ada jaminan yang diberikan bahwa pernyataan berwawasan ke depan itu akan terwujud, dan jangan terlalu bergantung pada pernyataan tersebut. Pengumuman ini bukan merupakan promosi keuangan atau penawaran untuk membeli atau menjual sekuritas di yurisdiksi mana pun.</div><div><br></div><div>Copyright 2026 GlobeNewswire, Inc.</div>   ]]></description>
<pubDate>Tue, 17 Nov 2026 19:59:00 +0700</pubDate>
</item>
<item>
<title>The Hoffman Agency Taps Darren Burns as Asia Pacific President</title>
<link>https://relleaseid.com/berita-bisnis/The-Hoffman-Agency-Taps-Darren-Burns-as-Asia-Pacific-President</link>
<description><![CDATA[<img src=https://relleaseid.com/photo/berita/dir112026/8378_The-Hoffman-Agency-Taps-Darren-Burns-as-Asia-Pacific-President.jpg border=0 hspace=5 align=left width=350 /><div>Source: The Hoffman Agency</div><div><br></div><div>Appointment builds on the independent consultancy&#039;s global ambitions</div><div><br></div><div>SILICON VALLEY, USA - Media OutReach Newswire - 17 November 2026- The Hoffman Agency, an independent global communications consultancy focused on the tech sector, has appointed Darren Burns as Asia Pacific President, effective January 18, 2027. Burns, who has more than 25 years of communications and agency leadership experience across Asia, will oversee the consultancy&#039;s regional operations and support its next phase of growth.</div><div><br></div><div>Previously holding senior leadership positions at Golin and Weber Shandwick, Burns brings a track record of building businesses, driving innovation and developing talent across the region.</div><div><br></div><div>According to Lou Hoffman, the firm&#039;s founder, you can throw existing playbooks out the window. "We&#039;re in a period of rethinking what it means to be a world-class communications consultancy. Darren&#039;s ability to see around corners, commercial sensibility, and people-first ethos ticked all the boxes for what we were looking for in this senior role."</div><div><br></div><div>The appointment comes as Hoffman continues to build on its global momentum. The consultancy has averaged over 15 percent compounded global growth over the past five years, with revenue projected to land at $43.7M this year.</div><div><br></div><div>This growth has been supported by strategic investments, including the acquisition of UK-based CCGroup, expansion into Thailand, and innovations such as GEDI, its proprietary generative engine visibility and optimization solution. The agency&#039;s multi-market proposition has also been a key driver, with clients supported across two or more markets accounting for more than half of global revenue. In APAC, such relationships are projected to account for approximately 65% of regional revenue in 2026.</div><div><br></div><div>Burns succeeds Caroline Hsu, who departs the agency after nine years.</div><div><br></div><div>Looking ahead, the agency sees further opportunities as AI and technology reshape industries, with more companies beyond the traditional technology sector seeking to tell their innovation stories. The agency aims to capitalize on this demand by combining its strategic storytelling expertise with an integrated global footprint spanning Asia, Europe and North America.</div><div><br></div><div>"What attracted me to Hoffman was the rare combination of independence, ambition and a genuine people-centric culture. Lou and his team have built something special - an agency with a distinctive culture and focus, an impressive track record of growth, and a reputation for outstanding work.</div><div><br></div><div>We&#039;re at a pivotal moment for our industry as technology reshapes how organizations communicate. Our industry must evolve at pace to meet these new demands. I believe agencies with the agility, creativity and courage to think differently have an extraordinary opportunity to lead change. Those with strong values and a vision will succeed, as they always do - and I&#039;m excited to build on Hoffman&#039;s momentum and help write its next chapter."</div><div><br></div><div>One of the few independent communications consultancies with global reach, Hoffman continues to invest in the leadership, talent and capabilities needed to help organizations navigate an increasingly complex world.</div><div><br></div><div>About The Hoffman Agency</div><div>Defining communications broadly to include digital, content marketing, thought leadership, as well as traditional PR, The Hoffman Agency marches to its own drummer. One of the few independent communications consultancies with global reach, it operates offices across Asia (Hong Kong, Singapore, Bangkok, Jakarta, Kuala Lumpur, Taipei, Seoul, Tokyo, Shanghai and Beijing), the U.S. (Silicon Valley, Portland and Boston) and Europe (London, Paris and Germany). The firm supports some of the biggest brands in the world, many of which prefer to remain unnamed (the client names we have permission to share publicly are on our website).</div><div><br></div><div>The issuer is solely responsible for the content of this announcement.</div><div><br></div><div>Hashtags: #TheHoffmanAgency #PR</div><div><br></div><div>https://www.hoffman.com/</div><div>https://www.linkedin.com/company/the-hoffman-agency</div><div>https://x.com/dailybrew</div><div>https://www.facebook.com/TheHoffmanAgency</div><div>https://www.instagram.com/hoffman_agency/</div>   ]]></description>
<pubDate>Tue, 17 Nov 2026 19:55:00 +0700</pubDate>
</item>
<item>
<title>AriBio&#039;s Oral AR1001 Meets Primary Efficacy Objective in Prespecified Monotherapy Population in Phase 3 POLARIS-AD Trial</title>
<link>https://relleaseid.com/berita-bisnis/AriBio--039-s-Oral-AR1001-Meets-Primary-Efficacy-Objective-in-Prespecified-Monotherapy-Population-in-Phase-3-POLARIS-AD-Trial</link>
<description><![CDATA[<img src=https://relleaseid.com/ border=0 hspace=5 align=left width=350 /><div><br></div><div>AR1001 met the primary endpoint in the prespecified Monotherapy population, with a CDR-SB treatment difference of -0.44 points versus placebo at Week 52 (p=0.0266), representing 31% slowing of clinical decline.</div><div>The difference between treatment and placebo in the Overall population numerically favored AR1001 but did not reach statistical significance.</div><div>Cognitive and functional secondary measures trended in favor of AR1001 across both populations, with a nominally significant MMSE finding in the Monotherapy population.</div><div>CSF biomarker findings support AR1001 target engagement in the central nervous system.</div><div>Topline results presented at CTAD 2026. AriBio plans to discuss the results with the FDA.</div><div><br></div><div>SEONGNAM-SI, South Korea and SAN DIEGO, Nov. 16, 2026 (GLOBE NEWSWIRE) -- AriBio Co., Ltd., a biotechnology company developing therapies for neurodegenerative diseases, today announced topline results from POLARIS-AD, its global Phase 3 trial of once-daily oral AR1001 in early Alzheimer&#039;s disease (AD).</div><div><br></div><div>The primary endpoint was evaluated in two prespecified primary populations, Overall and Monotherapy. The Monotherapy population was comprised of participants not receiving an acetylcholinesterase inhibitor or memantine at baseline. The study met its primary efficacy objective in the prespecified Monotherapy population (n=604), with AR1001 demonstrating a statistically significant treatment difference of &#8722;0.44 points versus placebo on the Clinical Dementia Rating-Sum of Boxes (CDR-SB) at Week 52 (p=0.0266), representing 31% slowing of clinical decline. In the Overall population (n=1,535), the treatment difference was &#8722;0.11 points versus placebo (p=0.4015), numerically favoring AR1001 but not reaching statistical significance.</div><div><br></div><div>"We started developing AR1001 with the goal of creating an oral treatment that could slow Alzheimer&#039;s progression and be practical for patients and care partners to use over the long term," said Jai-Jun Choung, Ph.D., Chairman and Chief Executive Officer of AriBio. "The 31% slowing of clinical decline at one year in the Monotherapy population supports our hypothesis. Our vision is to broaden the treatment options available to patients and families with a once-daily oral medicine. We are deeply grateful to the participants, care partners, investigators and clinical teams who made this global study possible."</div><div><br></div><div>Secondary cognitive and functional measures numerically favored AR1001 in both populations, with larger effects in the Monotherapy population. In the Monotherapy population, AR1001 showed a treatment difference of -1.16 points versus placebo on the Alzheimer&#039;s Disease Assessment Scale?Cognitive Subscale 13 (ADAS-Cog 13; p=0.0798). AR1001 also showed a 0.7-point treatment difference versus placebo on the Mini-Mental State Examination (MMSE; p=0.0232).</div><div><br></div><div>In prespecified CSF biomarker analyses, AR1001 increased cerebrospinal fluid (CSF) cyclic guanosine monophosphate (cGMP) levels versus placebo at Week 52 in both the Overall and Monotherapy populations (p<0.0001 and p=0.0058, respectively). These findings are consistent with its mechanism of action and support target engagement within the central nervous system. CSF p-tau217 results numerically favored AR1001 in both populations, with treatment differences versus placebo of -3.52 pg/mL in the Overall population (p= 0.1784) and -5.34 pg/mL in the Monotherapy (p=0.0402). No difference in the CSF A&#946;42/40 ratio was observed at 52 weeks. Additional biomarker analyses are ongoing to further characterize AR1001&#039;s biological effects.</div><div><br></div><div>AR1001 was generally well tolerated over the 52-week treatment phase. Treatment-emergent adverse events occurred in 69.0% of participants receiving AR1001 and 66.4% of those receiving placebo, and serious adverse events were similarly balanced (10.0% vs. 9.8%). Most adverse events were mild to moderate in severity. Fatal adverse events were reported in four participants (0.5%) receiving AR1001 and two (0.3%) receiving placebo. The most common non-serious adverse events with AR1001 were diarrhea (7.7% vs. 4.4% with placebo), falls (7.3% vs. 5.9%) and dizziness (6.1% vs. 3.1%). Adverse events led to discontinuation of study drug in 5.2% of AR1001-treated participants and 1.7% of placebo-treated participants. The most common adverse events that led to study drug discontinuation were diarrhea (0.7% vs 0% with placebo) and vomiting (0.4% vs 0%).</div><div><br></div><div>"The CDR-SB finding in the prespecified Monotherapy population and the safety profile are encouraging. The secondary endpoints and biomarker findings warrant further evaluation alongside the Overall population outcome to understand AR1001&#039;s therapeutic effects in early Alzheimer&#039;s disease," said Sharon J. Sha, M.D., M.S., Chief of the Memory Disorders Division at Stanford University and Global Principal Investigator of POLARIS-AD. "The work of POLARIS-AD is another step towards filling an unmet need in early Alzheimer&#039;s disease in which patients need more options for treatment."</div><div><br></div><div>"Participating in the 52-week treatment phase and the ongoing extension takes a sustained commitment from each participant and care partner," said James Rock, Chief Clinical Officer of AriBio. "We are immensely thankful to our clinical trial sites, participants and caregiver for their unwavering support and dedication to this trial. The ongoing extension phase of the trial will provide important data for understanding disease progress in the context of AR1001 treatment and inform us on the next stage of development for AR1001. We will continue our review of the data and discuss the complete findings with the FDA to inform next steps."</div><div><br></div><div>Dr. Sharon J. Sha presented the POLARIS-AD topline results at CTAD 2026 on Monday, November 16 in Boston. The presentation addressed efficacy and safety outcomes in the Overall and Monotherapy populations.</div><div><br></div><div>AriBio plans to present additional analyses at future scientific conferences and discuss the complete findings with the U.S. Food and Drug Administration to inform next steps for AR1001.</div><div><br></div><div>About POLARIS-AD</div><div>POLARIS-AD (NCT05531526) is a global, randomized, double-blind, placebo-controlled Phase 3 clinical trial evaluating the efficacy and safety of AR1001 in participants with early Alzheimer&#039;s disease. The study was initiated in December 2022 and enrolled 1,535 participants across approximately 230 clinical sites in 13 countries, including the United States, European Union member states, South Korea, China, Canada and the United Kingdom. </div><div><br></div><div>Participants were randomized to receive AR1001 30 mg or placebo once daily for 52 weeks. The primary endpoint was change from baseline to Week 52 in the Clinical Dementia Rating?Sum of Boxes (CDR-SB), a measure of cognitive and functional impairment evaluated in two prespecified primary populations, Overall and Monotherapy. </div><div><br></div><div>The primary efficacy objective required a statistically significant treatment difference versus placebo at Week 52 in at least one population under the prespecified multiplicity procedure. Additional assessments evaluated cognition, daily functioning and biomarkers associated with Alzheimer&#039;s disease. A total of 1,349 participants (87.9%) completed the 52-week double-blind treatment period. Of these, 1,284 (95.2%) entered the optional 52-week open-label extension phase, in which all participants receive AR1001 30 mg once daily. The extension phase is expected to conclude in the third quarter of 2027.</div><div><br></div><div>About AR1001</div><div>AR1001 is an investigational, once-daily oral small molecule developed by AriBio as a potential disease-modifying treatment for Alzheimer&#039;s disease and other neurodegenerative disorders. AR1001 is a blood-brain barrier-penetrant phosphodiesterase-5 (PDE5) inhibitor that enhances cyclic guanosine monophosphate (cGMP) signaling. Preclinical research supports its potential to act on multiple biological pathways implicated in Alzheimer&#039;s disease, including cerebral perfusion, neuroprotection, neuroinflammation and tau phosphorylation. </div><div><br></div><div>AR1001 is being evaluated in the global Phase 3 POLARIS-AD trial for early Alzheimer&#039;s disease. AR1001 has not been approved by the U.S. Food and Drug Administration or any other regulatory authority for Alzheimer&#039;s disease, and its safety and efficacy for this indication have not been established.</div><div><br></div><div>About AriBio</div><div>Founded in 2010, AriBio Co., Ltd. is a late clinical-stage biotechnology company headquartered in South Korea, with global clinical operations in San Diego, California, focused on developing therapies for neurodegenerative diseases and other areas of high unmet medical needs. The company&#039;s lead program, AR1001, is an investigational oral treatment candidate for Alzheimer&#039;s disease. AR1005 is an an oral treatment candidate in Phase 2 development for dementia with Lewy Bodies. AriBio is also advancing additional programs in dementia and related neurological disorders.&#8239;</div><div><br></div><div>Forward-looking statements</div><div>This press release contains forward-looking statements regarding AR1001&#039;s potential therapeutic benefits; additional analyses and presentations of POLARIS-AD results; the ongoing open-label extension and its expected completion; planned regulatory discussions; and future development of AriBio&#039;s pipeline. These statements reflect current expectations and assumptions and are subject to risks and uncertainties that could cause actual results or timelines to differ materially.</div><div><br></div><div>Such risks include additional analyses or safety findings that may change the interpretation of the reported results; uncertainty regarding whether the Monotherapy findings will be confirmed in future studies or whether biomarker changes will translate into sustained clinical benefit; delays in completing the extension; and changes in development plans or resource availability. Regulatory authorities may interpret the results differently, require additional analyses or clinical trials, or delay or decline approval. The reported results do not guarantee regulatory approval.</div><div><br></div><div>AR1001 remains investigational for Alzheimer&#039;s disease, and its safety and efficacy for this indication have not been established. Forward-looking statements speak only as of the date of this release. Readers should not place undue reliance on them. AriBio undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise, except as required by applicable law.</div><div><br></div><div>Copyright 2026 GlobeNewswire, Inc.</div>   ]]></description>
<pubDate>Tue, 17 Nov 2026 19:48:00 +0700</pubDate>
</item>
<item>
<title>AGC Biologics Welcomes Multiple Cell Therapy Projects to New Yokohama Site</title>
<link>https://relleaseid.com/berita-bisnis/AGC-Biologics-Welcomes-Multiple-Cell-Therapy-Projects-to-New-Yokohama-Site</link>
<description><![CDATA[<img src=https://relleaseid.com/photo/berita/dir112026/8548_AGC-Biologics-Welcomes-Multiple-Cell-Therapy-Projects-to-New-Yokohama-Site.jpg border=0 hspace=5 align=left width=350 /><div><br></div><div>Developers ranging from academic institutions to biotechnology companies select AGC Biologics for its proven commercial track record</div><div><br></div><div>Showcases momentum for Japan&#039;s cell and gene therapy ecosystem following proactive government initiatives</div><div><br></div><div>YOKOHAMA, Japan, Nov. 16, 2026 (GLOBE NEWSWIRE) -- While there is growing interest and momentum for cell and gene therapy development in Japan, there are a limited number of CDMOs with the institutional knowledge, manufacturing prowess, talent development, and international network. To advance their projects in a fast-paced, resource-constrained environment, three biopharma developers including the Institute of Science Tokyo have selected AGC Biologics to provide cell therapy services from its new Yokohama location.</div><div><br></div><div>AGC established its cell therapy services in Yokohama in July 2025, bringing together two strong legacies: thirty years of expertise and the track record of the AGC Biologics Milan site, and AGC Group&#039;s century-plus manufacturing excellence in Japan. Combined, those legacies position AGC to meet the burgeoning needs of the cell and gene therapy industry.</div><div><br></div><div>As part of these new projects, the AGC Biologics Yokohama site will provide services such as process transfer and manufacturing services for pre-clinical and clinical trials. Core technologies available for developers with diverse needs include induced pluripotent stem cells, mesenchymal stem cells, hematopoietic stem cells, exosomes, and CAR-T cell therapies.</div><div><br></div><div>Supporting Clinical Translation of Virus-Specific T Cell Therapy Research</div><div><br></div><div>Among the projects the Yokohama site will support is a research program led by the Institute of Science Tokyo aimed at advancing third-party virus-specific T cell therapy for treatment-resistant adenovirus infections following hematopoietic cell transplantation toward clinical application.</div><div><br></div><div>"Viral infections following hematopoietic cell transplantation represent a major clinical challenge in patients with compromised immune function and can lead to severe, potentially life-threatening complications," said Takahiro Kamiya, M.D., Ph.D., Junior Associate Professor at the Institute of Science Tokyo Graduate School of Medical and Dental Sciences. "With support from the Japanese Agency for Medical Research and Development under its Research Program for Intractable Diseases, we are advancing the research and development of virus-specific T-cell therapy toward clinical implementation for refractory adenovirus infections following hematopoietic cell transplantation."</div><div><br></div><div>At the Yokohama site, AGC Biologics supports this program through process development and analytical method development activities intended to facilitate future clinical and manufacturing implementation.</div><div><br></div><div>Coordination with the AGC Biologics Milan Cell and Gene Center of Excellence</div><div><br></div><div>One of the new projects involves the transfer of a customer program from the Milan site to the Yokohama site, where AGC will conduct future development and manufacturing activities. Through coordination across its global network, AGC Biologics provides flexible development and manufacturing support tailored to customers&#039; evolving needs and business environments.</div><div><br></div><div>"By combining technologies developed across our global network with AGC&#039;s unique materials expertise, we provide globally aligned development support services to customers worldwide," said Tadashi Murano, President of AGC Life Science Company. "Going forward, we will continue to provide integrated support from early-stage development through commercialization, helping accelerate our customers&#039; research and development activities."</div><div><br></div><div>"AGC Biologics has accumulated extensive experience in the development and manufacturing of cell therapy products through its global operations," said Takahiro. "As we prepare for this collaboration, we have also been impressed by the strength of its research and development capabilities, its robust infrastructure, and the dedication and enthusiasm of its team."</div><div><br></div><div>Development and manufacturing provided by the AGC Biologics Cell and Gene Technologies Division has led to 18 commercial approvals for its customers and their products.</div><div><br></div><div>Improved landscape for cell and gene therapy development in Japan</div><div><br></div><div>As outlined in a recent analysis by Dark Horse Consulting and AGC Biologics, proactive government action and regulatory changes have brought a new wave of early-stage development and attention to cell and gene therapy development in Japan.</div><div><br></div><div>"As Western biopharmaceuticals and investors increasingly turn their attention eastward, much of the spotlight has centered on China, driven by its scale, clinical speed and cost advantages," according to H. Deborah Chen and Kang Liu, the authors of the new report, From Laboratory to Launchpad: Japan&#039;s Cell and Gene Therapy Ecosystem Hits Its Stride. "Yet, Japan with its deep scientific expertise, expanding manufacturing infrastructure, and strong global accessibility represents both a growing market and a potential hub for CGT innovation across Asia that should not be overlooked."</div><div><br></div><div>The full report outlines why Japan presents a compelling opportunity for global CGT developers, as well as some key considerations for developers aiming to build a presence or conduct trials in Japan.</div><div><br></div><div>Frequently Asked Questions (FAQs):</div><div><br></div><div>Will the Yokohama cell therapy services only be approved by the PMDA, or will it pursue products for additional international regulatory approvals?</div><div><br></div><div>The Yokohama cell therapy services suite will not be limited to any one jurisdiction and will pursue regulatory approvals as desired by the customers and the markets they wish to serve, including the PMDA, FDA, EMA, and others.</div><div><br></div><div>The AGC Biologics unified global quality system brings a consistent track record of regulatory success and manufacturing excellence to its partnerships and has worked with regulatory bodies around the world and on four different continents. AGC Biologics has passed more than 100 regulatory inspections across agencies including the FDA, EMA, and PMDA.</div><div><br></div><div>What specifically is the SAKIGAKE designation and what is the status of it?</div><div><br></div><div>The SAKIGAKE designation system was initiated by Japan&#039;s Ministry of Health, Labor and Welfare in 2015 to further accelerate regulatory approvals for innovative therapies. Similar to the U.S. FDA&#039;s Breakthrough Therapy designation and the EU EMA&#039;s Priority Medicines program, the SAKIGAKE regulatory initiative works to expedite access to treatments for serious or life-threatening conditions.</div><div><br></div><div>SAKIGAKE status is granted to candidates demonstrating novel mechanisms of action with promising efficacy or safety data, and those products have a review period closer to six months and prioritized consultation with the PMDA.</div><div><br></div><div>As of June 2026, four of the 25 regenerative medicine products receiving approval in Japan had SAKIGAKE designation. Three of the four were from Japanese drug developers and one was a global sponsor.</div><div><br></div><div>In late 2025 and early 2026 alone, four new SAKIGAKE designations were awarded to sponsors outside of Japan.</div><div><br></div><div>How does Japan encourage orphan drug development?</div><div><br></div><div>Japan&#039;s Ministry of Health, Labor and Welfare has an orphan designation for products targeting conditions with fewer than 50,000 patients in Japan that have a high unmet medical need and lack effective existing treatments.</div><div><br></div><div>With this designation, sponsors have:</div><div><br></div><div>Priority review timelines ( 9 months)</div><div>10-year re-examination period</div><div>Flexibility for global programs (Does not require a Japan-first or Japan-simultaneous submission)</div><div><br></div><div>More details are accessible through the PMDA&#039;s Overview of Orphan Drug Designation.</div><div><br></div><div>About Institute of Science Tokyo</div><div>Institute of Science Tokyo (Science Tokyo) was established on October 1, 2024, following the merger between Tokyo Medical and Dental University (TMDU) and Tokyo Institute of Technology (Tokyo Tech), with the mission of "Advancing science and human wellbeing to create value for and with society."</div><div><br></div><div>About AGC Biologics</div><div>AGC Biologics is a leading global biopharmaceutical Contract Development and Manufacturing Organization (CDMO) with a strong commitment to delivering friendly and expert services as we work side-by-side with our clients and partners. We provide world-class development and manufacturing of mammalian and microbial-based therapeutic proteins, plasmid DNA (pDNA), messenger RNA (mRNA), viral vectors, and genetically engineered cells. Our global network spans the U.S., Europe, and Asia, with locations in Seattle, Washington; Copenhagen, Denmark; Heidelberg, Germany; Milan, Italy; and Chiba and Yokohama, Japan. </div><div><br></div><div>AGC Biologics is a part of AGC Inc.&#039;s Life Science Business. The Life Science Business runs eight facilities focused on biopharmaceuticals, advanced therapies, small molecule active pharmaceutical ingredients, and agrochemicals. To learn more, visit www.agcbio.com.</div><div><br></div><div>Copyright 2026 GlobeNewswire, Inc.</div>   ]]></description>
<pubDate>Tue, 17 Nov 2026 07:31:00 +0700</pubDate>
</item>
<item>
<title>Digit9 selects Clear Junction to support international remittance growth</title>
<link>https://relleaseid.com/berita-bisnis/Digit9-selects-Clear-Junction-to-support-international-remittance-growth</link>
<description><![CDATA[<img src=https://relleaseid.com/photo/berita/dir112026/8932_Digit9-selects-Clear-Junction-to-support-international-remittance-growth.jpg border=0 hspace=5 align=left width=350 /><div><br></div><div>The agreement will support GBP and EUR collections and payouts, alongside multi-currency SWIFT connectivity, as Digit9 expands its international payments network.</div><div><br></div><div>London, UK, Nov. 16, 2026 (GLOBE NEWSWIRE) -- Clear Junction has been selected by Digit9, a part of LuLu Financial Holdings group, to provide GBP and EUR collection and payout infrastructure, alongside multi-currency SWIFT services for institutional payments as the company expands its international payments business.</div><div><br></div><div>Digit9, a cross-border payments orchestration platform, is growing its network of institutional payment partners and international payout capabilities. This expansion corresponds with an increasing need to manage incoming and outgoing payments across institutional partners operating with different funding models, currencies and payment requirements.</div><div><br></div><div>Clear Junction will provide infrastructure to accommodate these requirements, including a Single IBAN account for bulk payments from various payment institutions and named virtual IBANs (vIBANs) to identify and reconcile payments associated with underlying retail and corporate customers. Clear Junction also supports GBP and EUR payouts, alongside eligible incoming and outgoing institutional transfers through its multi-currency SWIFT solution.</div><div><br></div><div>This combination allows Digit9 to manage collections, reconciliation and payouts across different currencies and institutional relationships. Clear Junction has worked closely with Digit9 to structure the solution around its operational requirements, with appropriate compliance controls built into the agreed model.</div><div><br></div><div>Shafeez Ahamed, Deputy CEO at Digit9, said:</div><div><br></div><div>"At Digit9, our vision is to make cross-border payments simpler, more accessible and more adaptable to the needs of financial institutions. We are bringing that vision to life by combining global reach with the capabilities needed to serve institutions operating across different markets.</div><div><br></div><div>Our collaboration with Clear Junction strengthens our GBP and EUR collection and payout capabilities, alongside multi-currency SWIFT connectivity, broadening the range of international payment flows we currently support."</div><div><br></div><div>Olga Mackintosh, Chief Commercial Officer at Clear Junction, commented:</div><div><br></div><div>"Payment infrastructure has to reflect the way a client&#039;s business actually operates. In Digit9&#039;s case, that meant understanding different collection and payout needs, the institutions involved and the infrastructure required to support them.</div><div><br></div><div>We&#039;ve worked closely with Digit9 to bring together the collection, payout and international payment capabilities that suit their operating model. It&#039;s a good example of how we approach complex institutional requirements, with compliance built in from the outset."</div><div><br></div><div>About Clear Junction</div><div>Clear Junction provides compliance-first payment and account infrastructure for licensed financial institutions.</div><div><br></div><div>We help banks, EMIs, payment institutions, PSPs, remittance providers, FX firms, acquirers and digital asset businesses access GBP and EUR accounts, virtual IBANs, payment rails and eligible stablecoin payment flows.</div><div><br></div><div>Our platform supports:</div><div><br></div><div>Correspondent accounts for institutional and client payments</div><div>Collection accounts for receiving and managing high volumes of payments</div><div>Virtual IBANs (vIBANs) for customers, merchants and partners (Please hyperlink "virtual IBANs" to our product page: https://clearjunction.com/products/virtual-iban-accounts/)</div><div>GBP and EUR payment rails, including Faster Payments, CHAPS, SEPA and SEPA Instant</div><div>FX and treasury services for cross-border payments and liquidity management</div><div>Eligible stablecoin pay-ins and pay-outs, connecting fiat and onChain settlement</div><div>API and web-based access for payments, reconciliation and reporting</div><div>Clear Junction Group provides payment and digital asset services through authorised and registered entities in the UK and Canada:</div><div><br></div><div>Clear Junction Limited</div><div><br></div><div>An Electronic Money Institution authorised by the Financial Conduct Authority (FCA), FRN 900684.</div><div><br></div><div>Clear Junction Digital Limited</div><div><br></div><div>An MLRs-registered cryptoasset business registered with the Financial Conduct Authority (FCA), FRN 900696.</div><div><br></div><div>Clear Junction Canada Limited</div><div><br></div><div>A Money Services Business registered with FINTRAC, registration number M23483057.</div><div><br></div><div>Since 2016, Clear Junction has supported financial institutions with the infrastructure they need to collect, move, reconcile and manage money across markets, currencies and payment rails.</div><div><br></div><div>About Digit9</div><div>Digit9 is a financial services and fintech solutions provider specialising in cross-border payments, foreign exchange and institutional payment solutions. Digit9 is part of LuLu Financial Holdings, a global financial services group with a presence across more than 10 countries. </div><div><br></div><div>Digit9 enables banks, fintechs and financial institutions to build, manage and scale international payment services, supported by a global payout network of over 2,000 partners and infrastructure capable of processing more than 300 concurrent transactions per second. With capabilities including Build Your Own Network (BYON), flexible payment routing and AI-driven treasury management, the company enables institutions to optimise liquidity, streamline payment operations and expand their international reach.</div><div><br></div><div>Combining global financial expertise with intelligent technology and scalable infrastructure, Digit9 is simplifying cross-border money movement and advancing a more connected, efficient and accessible global payments ecosystem.</div><div><br></div><div>Copyright 2026 GlobeNewswire, Inc.</div>   ]]></description>
<pubDate>Tue, 17 Nov 2026 07:21:00 +0700</pubDate>
</item>
<item>
<title>From Physics to Factory: NAED&#039;s PV-1 Delivers the Tandem Era at 96,000 WPH</title>
<link>https://relleaseid.com/berita-bisnis/From-Physics-to-Factory--NAED--039-s-PV-1-Delivers-the-Tandem-Era-at-96-000-WPH</link>
<description><![CDATA[<img src=https://relleaseid.com/photo/berita/dir112026/2882_From-Physics-to-Factory--NAED--039-s-PV-1-Delivers-the-Tandem-Era-at-96-000-WPH.jpg border=0 hspace=5 align=left width=350 /><div><br></div><div>96,000 wafers an hour. Six lines. One tandem platform</div><div><br></div><div>MIAMI, Nov. 16, 2026 (GLOBE NEWSWIRE) -- Four years. Thousands of hours. Countless tests. And now, the moment the industry has been waiting for. NAED Energy Holding Inc. today announced the completion of the full engineering package for PV-1, a vertical in-line PECVD-V production system built for two-terminal perovskite/silicon heterojunction tandem cells (T2X). A single PV-1 line is rated at 16,000 wafers per hour; a six-line site reaches 96,000 wafers per hour.</div><div><br></div><div>The package runs from device physics through 14 complete machine build sets, utility hook-ups, a full bill of materials and large-format print sets, ready for scale. Wafers travel standing on edge in vertical carriers, 400 at a time, through a continuous vacuum line. Halfway through, the whole carrier is turned 180 in vacuum so both faces are coated without a single wafer being touched. No hands, from beginning to end.</div><div><br></div><div>The Tandem Production Breakthrough Everyone Was Waiting For</div><div><br></div><div>Key figures:</div><div><br></div><div>16,000 wafers per hour per line; 96,000 wafers per hour for a six-line site</div><div>16,007 wph verified average across three certified 24-hour production runs, all within the TDS-001 gate</div><div>34.4 % modelled T2X cell efficiency; 7.48 W per half-cell at standard test conditions</div><div>788.1 MW DC per year per line and 4,728.5 MW ( 4.7 GW) for six lines, on a production basis</div><div>Wet bench plus 13 PV-1 machines per line, from wet bench to rear print</div><div>All acceptance gates passed: 24/24 tool acceptance criteria, 12/12 accelerated reliability sequences, 19/19 calibrated instruments</div><div>709 part numbers in the complete bill of materials</div><div>Five US utility applications, patent pending</div><div><br></div><div>The Physics: Why Tandem</div><div><br></div><div>A single silicon junction loses most of the energy of blue and green photons as heat. T2X stacks a wide-bandgap perovskite top cell (about 1.7 eV) on a silicon heterojunction bottom cell (about 1.1 eV). The top cell converts the high-energy light and passes the red and infrared to the silicon beneath.</div><div><br></div><div>In a two-terminal tandem the two subcells are connected in series: they share one current and their voltages add. The design balances the two subcells so that neither limits the current. At that balance point the modelled T2X half-cell delivers 7.48 W, a conversion efficiency of 34.4 % under standard test conditions (AM1.5G, 1,000 W/m?, 25 ?C).</div><div><br></div><div>The Finished T2X Cell</div><div><br></div><div>The finished T2X cell is a G12 half-cell, 210 ? 105 mm, with 217.2 cm? of active area. Each face carries 68 fine contact fingers at 3.05 mm pitch and no busbars, keeping shading low and the face clear for light. The front of the cell is the perovskite top cell; the rear is the silicon heterojunction bottom cell with its transparent rear electrode and printed contact grid.</div><div><br></div><div>The Line: From Wafer to Tandem-Ready Cell</div><div><br></div><div>PV-1 carries wafers standing on edge in vertical carriers, 400 at a time, through a continuous vacuum line. Halfway through, the whole carrier is lifted and turned 180? in vacuum, so both faces are coated without a single wafer being touched (patent pending). The line runs through 14 stations:</div><div><br></div><div><table class="MsoNormalTable" border="0" cellspacing="0" cellpadding="0">
 <tbody><tr>
  <td valign="top" style="border:solid black 1.0pt;padding:.75pt .75pt .75pt 7.5pt">
  <p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height:
  normal">#<o:p></o:p></p>
  </td>
  <td valign="top" style="border:solid black 1.0pt;border-left:none;padding:.75pt .75pt .75pt 7.5pt">
  <p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height:
  normal">Station<o:p></o:p></p>
  </td>
  <td valign="top" style="border:solid black 1.0pt;border-left:none;padding:.75pt .75pt .75pt 7.5pt">
  <p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height:
  normal">Function<o:p></o:p></p>
  </td>
 </tr>
 <tr>
  <td valign="top" style="border:solid black 1.0pt;border-top:none;padding:.75pt .75pt .75pt 7.5pt">
  <p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height:
  normal">1<o:p></o:p></p>
  </td>
  <td valign="top" style="border-top:none;border-left:none;border-bottom:solid black 1.0pt;
  border-right:solid black 1.0pt;padding:.75pt .75pt .75pt 7.5pt">
  <p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height:
  normal">Wet bench (Qyrion 1000)<o:p></o:p></p>
  </td>
  <td valign="top" style="border-top:none;border-left:none;border-bottom:solid black 1.0pt;
  border-right:solid black 1.0pt;padding:.75pt .75pt .75pt 7.5pt">
  <p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height:
  normal">Cleans and textures the silicon
  wafers<o:p></o:p></p>
  </td>
 </tr>
 <tr>
  <td valign="top" style="border:solid black 1.0pt;border-top:none;padding:.75pt .75pt .75pt 7.5pt">
  <p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height:
  normal">2<o:p></o:p></p>
  </td>
  <td valign="top" style="border-top:none;border-left:none;border-bottom:solid black 1.0pt;
  border-right:solid black 1.0pt;padding:.75pt .75pt .75pt 7.5pt">
  <p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height:
  normal">V-Loader (VL-1)<o:p></o:p></p>
  </td>
  <td valign="top" style="border-top:none;border-left:none;border-bottom:solid black 1.0pt;
  border-right:solid black 1.0pt;padding:.75pt .75pt .75pt 7.5pt">
  <p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height:
  normal">Loads wafers edge-on into twin
  vertical carriers<o:p></o:p></p>
  </td>
 </tr>
 <tr>
  <td valign="top" style="border:solid black 1.0pt;border-top:none;padding:.75pt .75pt .75pt 7.5pt">
  <p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height:
  normal">3<o:p></o:p></p>
  </td>
  <td valign="top" style="border-top:none;border-left:none;border-bottom:solid black 1.0pt;
  border-right:solid black 1.0pt;padding:.75pt .75pt .75pt 7.5pt">
  <p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height:
  normal">Load lock (LL)<o:p></o:p></p>
  </td>
  <td valign="top" style="border-top:none;border-left:none;border-bottom:solid black 1.0pt;
  border-right:solid black 1.0pt;padding:.75pt .75pt .75pt 7.5pt">
  <p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height:
  normal">Takes the carriers from atmosphere
  into vacuum<o:p></o:p></p>
  </td>
 </tr>
 <tr>
  <td valign="top" style="border:solid black 1.0pt;border-top:none;padding:.75pt .75pt .75pt 7.5pt">
  <p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height:
  normal">4<o:p></o:p></p>
  </td>
  <td valign="top" style="border-top:none;border-left:none;border-bottom:solid black 1.0pt;
  border-right:solid black 1.0pt;padding:.75pt .75pt .75pt 7.5pt">
  <p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height:
  normal">Process module PM1<o:p></o:p></p>
  </td>
  <td valign="top" style="border-top:none;border-left:none;border-bottom:solid black 1.0pt;
  border-right:solid black 1.0pt;padding:.75pt .75pt .75pt 7.5pt">
  <p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height:
  normal">PECVD-V deposition, front face<o:p></o:p></p>
  </td>
 </tr>
 <tr>
  <td valign="top" style="border:solid black 1.0pt;border-top:none;padding:.75pt .75pt .75pt 7.5pt">
  <p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height:
  normal">5<o:p></o:p></p>
  </td>
  <td valign="top" style="border-top:none;border-left:none;border-bottom:solid black 1.0pt;
  border-right:solid black 1.0pt;padding:.75pt .75pt .75pt 7.5pt">
  <p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height:
  normal">Transfer module TM1<o:p></o:p></p>
  </td>
  <td valign="top" style="border-top:none;border-left:none;border-bottom:solid black 1.0pt;
  border-right:solid black 1.0pt;padding:.75pt .75pt .75pt 7.5pt">
  <p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height:
  normal">Moves carriers between process
  modules under vacuum<o:p></o:p></p>
  </td>
 </tr>
 <tr>
  <td valign="top" style="border:solid black 1.0pt;border-top:none;padding:.75pt .75pt .75pt 7.5pt">
  <p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height:
  normal">6<o:p></o:p></p>
  </td>
  <td valign="top" style="border-top:none;border-left:none;border-bottom:solid black 1.0pt;
  border-right:solid black 1.0pt;padding:.75pt .75pt .75pt 7.5pt">
  <p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height:
  normal">Process module PM2<o:p></o:p></p>
  </td>
  <td valign="top" style="border-top:none;border-left:none;border-bottom:solid black 1.0pt;
  border-right:solid black 1.0pt;padding:.75pt .75pt .75pt 7.5pt">
  <p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height:
  normal">PECVD-V deposition, front face<o:p></o:p></p>
  </td>
 </tr>
 <tr>
  <td valign="top" style="border:solid black 1.0pt;border-top:none;padding:.75pt .75pt .75pt 7.5pt">
  <p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height:
  normal">7<o:p></o:p></p>
  </td>
  <td valign="top" style="border-top:none;border-left:none;border-bottom:solid black 1.0pt;
  border-right:solid black 1.0pt;padding:.75pt .75pt .75pt 7.5pt">
  <p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height:
  normal">Carrier rotation station (CRM-ST)<o:p></o:p></p>
  </td>
  <td valign="top" style="border-top:none;border-left:none;border-bottom:solid black 1.0pt;
  border-right:solid black 1.0pt;padding:.75pt .75pt .75pt 7.5pt">
  <p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height:
  normal">The 180? whole-carrier turn, in
  vacuum<o:p></o:p></p>
  </td>
 </tr>
 <tr>
  <td valign="top" style="border:solid black 1.0pt;border-top:none;padding:.75pt .75pt .75pt 7.5pt">
  <p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height:
  normal">8<o:p></o:p></p>
  </td>
  <td valign="top" style="border-top:none;border-left:none;border-bottom:solid black 1.0pt;
  border-right:solid black 1.0pt;padding:.75pt .75pt .75pt 7.5pt">
  <p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height:
  normal">Process module PM3<o:p></o:p></p>
  </td>
  <td valign="top" style="border-top:none;border-left:none;border-bottom:solid black 1.0pt;
  border-right:solid black 1.0pt;padding:.75pt .75pt .75pt 7.5pt">
  <p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height:
  normal">PECVD-V deposition, rear face<o:p></o:p></p>
  </td>
 </tr>
 <tr>
  <td valign="top" style="border:solid black 1.0pt;border-top:none;padding:.75pt .75pt .75pt 7.5pt">
  <p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height:
  normal">9<o:p></o:p></p>
  </td>
  <td valign="top" style="border-top:none;border-left:none;border-bottom:solid black 1.0pt;
  border-right:solid black 1.0pt;padding:.75pt .75pt .75pt 7.5pt">
  <p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height:
  normal">Transfer module TM2<o:p></o:p></p>
  </td>
  <td valign="top" style="border-top:none;border-left:none;border-bottom:solid black 1.0pt;
  border-right:solid black 1.0pt;padding:.75pt .75pt .75pt 7.5pt">
  <p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height:
  normal">Vacuum transfer<o:p></o:p></p>
  </td>
 </tr>
 <tr>
  <td valign="top" style="border:solid black 1.0pt;border-top:none;padding:.75pt .75pt .75pt 7.5pt">
  <p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height:
  normal">10<o:p></o:p></p>
  </td>
  <td valign="top" style="border-top:none;border-left:none;border-bottom:solid black 1.0pt;
  border-right:solid black 1.0pt;padding:.75pt .75pt .75pt 7.5pt">
  <p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height:
  normal">Process module PM4<o:p></o:p></p>
  </td>
  <td valign="top" style="border-top:none;border-left:none;border-bottom:solid black 1.0pt;
  border-right:solid black 1.0pt;padding:.75pt .75pt .75pt 7.5pt">
  <p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height:
  normal">PECVD-V deposition, rear face<o:p></o:p></p>
  </td>
 </tr>
 <tr>
  <td valign="top" style="border:solid black 1.0pt;border-top:none;padding:.75pt .75pt .75pt 7.5pt">
  <p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height:
  normal">11<o:p></o:p></p>
  </td>
  <td valign="top" style="border-top:none;border-left:none;border-bottom:solid black 1.0pt;
  border-right:solid black 1.0pt;padding:.75pt .75pt .75pt 7.5pt">
  <p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height:
  normal">Unload lock (UL)<o:p></o:p></p>
  </td>
  <td valign="top" style="border-top:none;border-left:none;border-bottom:solid black 1.0pt;
  border-right:solid black 1.0pt;padding:.75pt .75pt .75pt 7.5pt">
  <p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height:
  normal">Returns the carriers to atmosphere<o:p></o:p></p>
  </td>
 </tr>
 <tr>
  <td valign="top" style="border:solid black 1.0pt;border-top:none;padding:.75pt .75pt .75pt 7.5pt">
  <p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height:
  normal">12<o:p></o:p></p>
  </td>
  <td valign="top" style="border-top:none;border-left:none;border-bottom:solid black 1.0pt;
  border-right:solid black 1.0pt;padding:.75pt .75pt .75pt 7.5pt">
  <p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height:
  normal">Unloader (UN-1)<o:p></o:p></p>
  </td>
  <td valign="top" style="border-top:none;border-left:none;border-bottom:solid black 1.0pt;
  border-right:solid black 1.0pt;padding:.75pt .75pt .75pt 7.5pt">
  <p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height:
  normal">Transfers wafers to trays without
  contact<o:p></o:p></p>
  </td>
 </tr>
 <tr>
  <td valign="top" style="border:solid black 1.0pt;border-top:none;padding:.75pt .75pt .75pt 7.5pt">
  <p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height:
  normal">13<o:p></o:p></p>
  </td>
  <td valign="top" style="border-top:none;border-left:none;border-bottom:solid black 1.0pt;
  border-right:solid black 1.0pt;padding:.75pt .75pt .75pt 7.5pt">
  <p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height:
  normal">In-line PVD (ITO-1)<o:p></o:p></p>
  </td>
  <td valign="top" style="border-top:none;border-left:none;border-bottom:solid black 1.0pt;
  border-right:solid black 1.0pt;padding:.75pt .75pt .75pt 7.5pt">
  <p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height:
  normal">Transparent conductive and
  interconnect layers<o:p></o:p></p>
  </td>
 </tr>
 <tr>
  <td valign="top" style="border:solid black 1.0pt;border-top:none;padding:.75pt .75pt .75pt 7.5pt">
  <p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height:
  normal">14<o:p></o:p></p>
  </td>
  <td valign="top" style="border-top:none;border-left:none;border-bottom:solid black 1.0pt;
  border-right:solid black 1.0pt;padding:.75pt .75pt .75pt 7.5pt">
  <p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height:
  normal">Rear print and cure (RP-1)<o:p></o:p></p>
  </td>
  <td valign="top" style="border-top:none;border-left:none;border-bottom:solid black 1.0pt;
  border-right:solid black 1.0pt;padding:.75pt .75pt .75pt 7.5pt">
  <p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height:
  normal">Prints and cures the rear contact
  grid<o:p></o:p></p>
  </td>
 </tr>
</tbody></table>

<p class="MsoNormal" style="mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;
line-height:normal"><br></p><p class="MsoNormal" style="mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;
line-height:normal">Ten doors per line
isolate the vacuum stations: two atmospheric lock doors and eight slit valves,
each interlocked so that a door opens only when both sides are matched.<o:p></o:p></p>

<p class="MsoNormal" style="mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;
line-height:normal">The Engineering Record<o:p></o:p></p>

<p class="MsoNormal" style="mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;
line-height:normal">Every machine on the
line is engineered to build level, and the whole line is documented at print
level on large-format 36 ? 24 in sheets. The record includes 14 machine build
sets in a 130-sheet master package plus a 23-sheet wet bench set; full-line, process,
assembly and parts, and utility hook-up print sets; door and slit-valve
specifications; 63 rendered close-ups of every utility connection; complete
facility design sets; and full-line renderings with a technical volume on the
PV-1 / T2X system. The eight large-format print sets alone run to 102 sheets.<o:p></o:p></p>

<p class="MsoNormal" style="mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;
line-height:normal">The Complete Bill of Materials<o:p></o:p></p>

<p class="MsoNormal" style="mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;
line-height:normal">The complete parts list
holds 709 part numbers across the wet bench and the 13 PV-1 machines, numbered
without gaps and totalled by formula.<o:p></o:p></p>

<table class="MsoNormalTable" border="0" cellspacing="0" cellpadding="0">
 <tbody><tr>
  <td valign="top" style="border:solid black 1.0pt;padding:.75pt .75pt .75pt 7.5pt">
  <p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height:
  normal">Total<o:p></o:p></p>
  </td>
  <td valign="top" style="border:solid black 1.0pt;border-left:none;padding:.75pt .75pt .75pt 7.5pt">
  <p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height:
  normal">Value<o:p></o:p></p>
  </td>
 </tr>
 <tr>
  <td valign="top" style="border:solid black 1.0pt;border-top:none;padding:.75pt .75pt .75pt 7.5pt">
  <p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height:
  normal">Part numbers<o:p></o:p></p>
  </td>
  <td valign="top" style="border-top:none;border-left:none;border-bottom:solid black 1.0pt;
  border-right:solid black 1.0pt;padding:.75pt .75pt .75pt 7.5pt">
  <p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height:
  normal">709<o:p></o:p></p>
  </td>
 </tr>
 <tr>
  <td valign="top" style="border:solid black 1.0pt;border-top:none;padding:.75pt .75pt .75pt 7.5pt">
  <p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height:
  normal">Hardware pieces per PV-1 line<o:p></o:p></p>
  </td>
  <td valign="top" style="border-top:none;border-left:none;border-bottom:solid black 1.0pt;
  border-right:solid black 1.0pt;padding:.75pt .75pt .75pt 7.5pt">
  <p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height:
  normal">2,807<o:p></o:p></p>
  </td>
 </tr>
 <tr>
  <td valign="top" style="border:solid black 1.0pt;border-top:none;padding:.75pt .75pt .75pt 7.5pt">
  <p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height:
  normal">Hardware pieces, six lines<o:p></o:p></p>
  </td>
  <td valign="top" style="border-top:none;border-left:none;border-bottom:solid black 1.0pt;
  border-right:solid black 1.0pt;padding:.75pt .75pt .75pt 7.5pt">
  <p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height:
  normal">16,842<o:p></o:p></p>
  </td>
 </tr>
 <tr>
  <td valign="top" style="border:solid black 1.0pt;border-top:none;padding:.75pt .75pt .75pt 7.5pt">
  <p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height:
  normal">Utility hook-up components per
  line<o:p></o:p></p>
  </td>
  <td valign="top" style="border-top:none;border-left:none;border-bottom:solid black 1.0pt;
  border-right:solid black 1.0pt;padding:.75pt .75pt .75pt 7.5pt">
  <p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height:
  normal">711<o:p></o:p></p>
  </td>
 </tr>
 <tr>
  <td valign="top" style="border:solid black 1.0pt;border-top:none;padding:.75pt .75pt .75pt 7.5pt">
  <p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height:
  normal">Vacuum doors and slit valves, six
  lines<o:p></o:p></p>
  </td>
  <td valign="top" style="border-top:none;border-left:none;border-bottom:solid black 1.0pt;
  border-right:solid black 1.0pt;padding:.75pt .75pt .75pt 7.5pt">
  <p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height:
  normal">60<o:p></o:p></p>
  </td>
 </tr>
</tbody></table>

<p class="MsoNormal" style="mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;
line-height:normal"><br></p><p class="MsoNormal" style="mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;
line-height:normal">Facility and Utilities<o:p></o:p></p>

<p class="MsoNormal" style="mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;
line-height:normal">The PV-1 facility is
designed in full, with every utility engineered and drawn from source to tool
connection: power and controls, process cooling and ultrapure water with
reclaim, bulk and specialty gases with monitored distribution, chemical supply
and wastewater treatment, vacuum and point-of-use abatement, and process
exhaust with gas detection.<o:p></o:p></p>

<p class="MsoNormal" style="mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;
line-height:normal">Capacity and Verification<o:p></o:p></p>

<p class="MsoNormal" style="mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;
line-height:normal">The capacity figures
below are verified. Under NAED specification TDS-001, measured performance is
published only after three consecutive 24-hour production runs under full
automated load remain within ?3.0% of the 16,000 wph design takt, with zero
catastrophic stops.<o:p></o:p></p>

<p class="MsoNormal" style="mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;
line-height:normal">The certified runs of
10?12 November 2026 produced 1,152,500 good wafers at an average of 16,007 wph
(+0.04% versus design), with a run-to-run spread of 0.18%. All three runs
passed the TDS-001 gate. Annual figures are derived from this verified line
rate using the model basis below.<o:p></o:p></p>

<table class="MsoNormalTable" border="0" cellspacing="0" cellpadding="0">
 <tbody><tr>
  <td valign="top" style="border:solid black 1.0pt;padding:.75pt .75pt .75pt 7.5pt">
  <p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height:
  normal">Quantity<o:p></o:p></p>
  </td>
  <td valign="top" style="border:solid black 1.0pt;border-left:none;padding:.75pt .75pt .75pt 7.5pt">
  <p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height:
  normal">Per line<o:p></o:p></p>
  </td>
  <td valign="top" style="border:solid black 1.0pt;border-left:none;padding:.75pt .75pt .75pt 7.5pt">
  <p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height:
  normal">Six lines<o:p></o:p></p>
  </td>
 </tr>
 <tr>
  <td valign="top" style="border:solid black 1.0pt;border-top:none;padding:.75pt .75pt .75pt 7.5pt">
  <p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height:
  normal">Rated throughput<o:p></o:p></p>
  </td>
  <td valign="top" style="border-top:none;border-left:none;border-bottom:solid black 1.0pt;
  border-right:solid black 1.0pt;padding:.75pt .75pt .75pt 7.5pt">
  <p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height:
  normal">16,000 wph<o:p></o:p></p>
  </td>
  <td valign="top" style="border-top:none;border-left:none;border-bottom:solid black 1.0pt;
  border-right:solid black 1.0pt;padding:.75pt .75pt .75pt 7.5pt">
  <p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height:
  normal">96,000 wph<o:p></o:p></p>
  </td>
 </tr>
 <tr>
  <td valign="top" style="border:solid black 1.0pt;border-top:none;padding:.75pt .75pt .75pt 7.5pt">
  <p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height:
  normal">Good cells per year<o:p></o:p></p>
  </td>
  <td valign="top" style="border-top:none;border-left:none;border-bottom:solid black 1.0pt;
  border-right:solid black 1.0pt;padding:.75pt .75pt .75pt 7.5pt">
  <p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height:
  normal">119.14 million<o:p></o:p></p>
  </td>
  <td valign="top" style="border-top:none;border-left:none;border-bottom:solid black 1.0pt;
  border-right:solid black 1.0pt;padding:.75pt .75pt .75pt 7.5pt">
  <p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height:
  normal">714.8 million<o:p></o:p></p>
  </td>
 </tr>
 <tr>
  <td valign="top" style="border:solid black 1.0pt;border-top:none;padding:.75pt .75pt .75pt 7.5pt">
  <p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height:
  normal">DC output per year, production
  basis<o:p></o:p></p>
  </td>
  <td valign="top" style="border-top:none;border-left:none;border-bottom:solid black 1.0pt;
  border-right:solid black 1.0pt;padding:.75pt .75pt .75pt 7.5pt">
  <p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height:
  normal">788.1 MW<o:p></o:p></p>
  </td>
  <td valign="top" style="border-top:none;border-left:none;border-bottom:solid black 1.0pt;
  border-right:solid black 1.0pt;padding:.75pt .75pt .75pt 7.5pt">
  <p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height:
  normal">4,728.5 MW<o:p></o:p></p>
  </td>
 </tr>
 <tr>
  <td valign="top" style="border:solid black 1.0pt;border-top:none;padding:.75pt .75pt .75pt 7.5pt">
  <p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height:
  normal">DC output per year, at modelled
  T2X efficiency<o:p></o:p></p>
  </td>
  <td valign="top" style="border-top:none;border-left:none;border-bottom:solid black 1.0pt;
  border-right:solid black 1.0pt;padding:.75pt .75pt .75pt 7.5pt">
  <p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height:
  normal">890.1 MW<o:p></o:p></p>
  </td>
  <td valign="top" style="border-top:none;border-left:none;border-bottom:solid black 1.0pt;
  border-right:solid black 1.0pt;padding:.75pt .75pt .75pt 7.5pt">
  <p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height:
  normal">5,340.9 MW<o:p></o:p></p>
  </td>
 </tr>
</tbody></table>

<p class="MsoNormal" style="mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;
line-height:normal"><br></p><p class="MsoNormal" style="mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;
line-height:normal">Model basis: 85.0%
overall equipment effectiveness (yield included). The production basis rates
each cell at a conservative 30% efficiency on 220.5 cm? (6.6 W per cell). The
second row applies the modelled 34.4% T2X efficiency on 217.2 cm? (7.48 W per
cell).<o:p></o:p></p>

<p class="MsoNormal" style="mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;
line-height:normal">Testing and Qualification<o:p></o:p></p>

<p class="MsoNormal" style="mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;
line-height:normal">Every PV-1 tool and the
T2X cell have passed NAED&#039;s acceptance gates, with each result traced to a
signed evidence record. Testing is carried out across eight dedicated
laboratories totalling 1,420 m?.<o:p></o:p></p>

<table class="MsoNormalTable" border="0" cellspacing="0" cellpadding="0">
 <tbody><tr>
  <td valign="top" style="border:solid black 1.0pt;padding:.75pt .75pt .75pt 7.5pt">
  <p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height:
  normal">Gate<o:p></o:p></p>
  </td>
  <td valign="top" style="border:solid black 1.0pt;border-left:none;padding:.75pt .75pt .75pt 7.5pt">
  <p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height:
  normal">Standard<o:p></o:p></p>
  </td>
  <td valign="top" style="border:solid black 1.0pt;border-left:none;padding:.75pt .75pt .75pt 7.5pt">
  <p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height:
  normal">Result<o:p></o:p></p>
  </td>
 </tr>
 <tr>
  <td valign="top" style="border:solid black 1.0pt;border-top:none;padding:.75pt .75pt .75pt 7.5pt">
  <p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height:
  normal">Production stability (TDS-001)<o:p></o:p></p>
  </td>
  <td valign="top" style="border-top:none;border-left:none;border-bottom:solid black 1.0pt;
  border-right:solid black 1.0pt;padding:.75pt .75pt .75pt 7.5pt">
  <p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height:
  normal">3 consecutive 24-hour runs within
  ?3.0% of design takt<o:p></o:p></p>
  </td>
  <td valign="top" style="border-top:none;border-left:none;border-bottom:solid black 1.0pt;
  border-right:solid black 1.0pt;padding:.75pt .75pt .75pt 7.5pt">
  <p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height:
  normal">3/3 passed; 16,007 wph average,
  0.18% spread<o:p></o:p></p>
  </td>
 </tr>
 <tr>
  <td valign="top" style="border:solid black 1.0pt;border-top:none;padding:.75pt .75pt .75pt 7.5pt">
  <p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height:
  normal">Factory and site acceptance
  (FAT/SAT)<o:p></o:p></p>
  </td>
  <td valign="top" style="border-top:none;border-left:none;border-bottom:solid black 1.0pt;
  border-right:solid black 1.0pt;padding:.75pt .75pt .75pt 7.5pt">
  <p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height:
  normal">24 vacuum, mechanical and process
  criteria<o:p></o:p></p>
  </td>
  <td valign="top" style="border-top:none;border-left:none;border-bottom:solid black 1.0pt;
  border-right:solid black 1.0pt;padding:.75pt .75pt .75pt 7.5pt">
  <p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height:
  normal">24/24 passed<o:p></o:p></p>
  </td>
 </tr>
 <tr>
  <td valign="top" style="border:solid black 1.0pt;border-top:none;padding:.75pt .75pt .75pt 7.5pt">
  <p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height:
  normal">Accelerated reliability,
  mini-modules<o:p></o:p></p>
  </td>
  <td valign="top" style="border-top:none;border-left:none;border-bottom:solid black 1.0pt;
  border-right:solid black 1.0pt;padding:.75pt .75pt .75pt 7.5pt">
  <p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height:
  normal">12 sequences to IEC 61215-2, IEC
  TS 62804 and ISOS protocols<o:p></o:p></p>
  </td>
  <td valign="top" style="border-top:none;border-left:none;border-bottom:solid black 1.0pt;
  border-right:solid black 1.0pt;padding:.75pt .75pt .75pt 7.5pt">
  <p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height:
  normal">12/12 passed; 95.9?99.5% power
  retained (limit 95.0%)<o:p></o:p></p>
  </td>
 </tr>
 <tr>
  <td valign="top" style="border:solid black 1.0pt;border-top:none;padding:.75pt .75pt .75pt 7.5pt">
  <p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height:
  normal">Instrument calibration<o:p></o:p></p>
  </td>
  <td valign="top" style="border-top:none;border-left:none;border-bottom:solid black 1.0pt;
  border-right:solid black 1.0pt;padding:.75pt .75pt .75pt 7.5pt">
  <p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height:
  normal">ISO/IEC 17025 traceability to NIST
  and PTB<o:p></o:p></p>
  </td>
  <td valign="top" style="border-top:none;border-left:none;border-bottom:solid black 1.0pt;
  border-right:solid black 1.0pt;padding:.75pt .75pt .75pt 7.5pt">
  <p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height:
  normal">19/19 instruments in date, 0
  overdue<o:p></o:p></p>
  </td>
 </tr>
</tbody></table>

<p class="MsoNormal" style="mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;
line-height:normal"><br></p><p class="MsoNormal" style="mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;
line-height:normal">Acceptance highlights
include a whole-chamber helium leak rate of 8.5 ? 10&#8315;?&#8304; mbar?L/s against a 1 ? 10&#8315;&#8313; limit, a 41-second 180 carrier turn inside a
57-second window, and a line index of 86.5 seconds against the 90-second
design. In reliability testing, mini-modules retained 96.4% of their power
after 1,000 hours of damp heat at 85 C and 85% relative humidity, and 97.0%
after 200 thermal cycles.<o:p></o:p></p>

<p class="MsoNormal" style="mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;
line-height:normal">Intellectual Property<o:p></o:p></p>

<p class="MsoNormal" style="mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;
line-height:normal">Five US utility
applications cover the PV-1 line and the T2X cell, all assigned to NAED Energy
Holding Inc. and patent pending.<o:p></o:p></p>

<table class="MsoNormalTable" border="0" cellspacing="0" cellpadding="0">
 <tbody><tr>
  <td valign="top" style="border:solid black 1.0pt;padding:.75pt .75pt .75pt 7.5pt">
  <p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height:
  normal">Application<o:p></o:p></p>
  </td>
  <td valign="top" style="border:solid black 1.0pt;border-left:none;padding:.75pt .75pt .75pt 7.5pt">
  <p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height:
  normal">Subject<o:p></o:p></p>
  </td>
 </tr>
 <tr>
  <td valign="top" style="border:solid black 1.0pt;border-top:none;padding:.75pt .75pt .75pt 7.5pt">
  <p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height:
  normal">US 19/853,551<o:p></o:p></p>
  </td>
  <td valign="top" style="border-top:none;border-left:none;border-bottom:solid black 1.0pt;
  border-right:solid black 1.0pt;padding:.75pt .75pt .75pt 7.5pt">
  <p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height:
  normal">Whole-carrier 180? rotation module
  (CRM-ST)<o:p></o:p></p>
  </td>
 </tr>
 <tr>
  <td valign="top" style="border:solid black 1.0pt;border-top:none;padding:.75pt .75pt .75pt 7.5pt">
  <p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height:
  normal">US 19/853,651<o:p></o:p></p>
  </td>
  <td valign="top" style="border-top:none;border-left:none;border-bottom:solid black 1.0pt;
  border-right:solid black 1.0pt;padding:.75pt .75pt .75pt 7.5pt">
  <p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height:
  normal">PECVD / PVD shared-carrier system<o:p></o:p></p>
  </td>
 </tr>
 <tr>
  <td valign="top" style="border:solid black 1.0pt;border-top:none;padding:.75pt .75pt .75pt 7.5pt">
  <p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height:
  normal">US 19/866,828<o:p></o:p></p>
  </td>
  <td valign="top" style="border-top:none;border-left:none;border-bottom:solid black 1.0pt;
  border-right:solid black 1.0pt;padding:.75pt .75pt .75pt 7.5pt">
  <p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height:
  normal">T2X tandem cell<o:p></o:p></p>
  </td>
 </tr>
 <tr>
  <td valign="top" style="border:solid black 1.0pt;border-top:none;padding:.75pt .75pt .75pt 7.5pt">
  <p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height:
  normal">US 19/866,836<o:p></o:p></p>
  </td>
  <td valign="top" style="border-top:none;border-left:none;border-bottom:solid black 1.0pt;
  border-right:solid black 1.0pt;padding:.75pt .75pt .75pt 7.5pt">
  <p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height:
  normal">Carrier pin wafer-retention system<o:p></o:p></p>
  </td>
 </tr>
 <tr>
  <td valign="top" style="border:solid black 1.0pt;border-top:none;padding:.75pt .75pt .75pt 7.5pt">
  <p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height:
  normal">US 19/866,838<o:p></o:p></p>
  </td>
  <td valign="top" style="border-top:none;border-left:none;border-bottom:solid black 1.0pt;
  border-right:solid black 1.0pt;padding:.75pt .75pt .75pt 7.5pt">
  <p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height:
  normal">PV-1 principal production line<o:p></o:p></p>
  </td>
 </tr>
</tbody></table>

<p class="MsoNormal"><o:p>&nbsp;</o:p></p></div><div>About NAED Energy Holding Inc.</div><div><br></div><div>NAED Energy Holding Inc. engineers and builds advanced energy manufacturing systems in-house, from wet bench to finished cell. The company operates in South Florida, New York and Nevada, with an international presence in Indonesia. Learn more at NAED.energy.</div><div><br></div><div>Forward-Looking Statements</div><div><br></div><div>This release contains forward-looking statements, including modelled cell efficiency, cell power and annual output derived from the verified line rate. Modelled values are engineering estimates, and actual performance may differ. NAED undertakes no obligation to update these statements except as required by law.</div><div><br></div><div>Copyright 2026 GlobeNewswire, Inc.</div>   ]]></description>
<pubDate>Tue, 17 Nov 2026 07:11:00 +0700</pubDate>
</item>
<item>
<title>Octave to Participate in Upcoming Investor Conferences</title>
<link>https://relleaseid.com/berita-bisnis/Octave-to-Participate-in-Upcoming-Investor-Conferences</link>
<description><![CDATA[<img src=https://relleaseid.com/photo/berita/dir112026/3706_Octave-to-Participate-in-Upcoming-Investor-Conferences.jpg border=0 hspace=5 align=left width=350 /><div><br></div><div>HUNTSVILLE, Ala., Nov. 16, 2026 (GLOBE NEWSWIRE) -- Octave Intelligence plc (Nasdaq New York: OCTV and Nasdaq Stockholm: OCTV SDB), a global leader in software for the world&#039;s most mission-critical facilities and infrastructure, today announced the company will be presenting at two upcoming investor conferences:</div><div><br></div><div>The RBC TIMT Conference in New York, NY. The presentation is scheduled for Tuesday, November 17, 2026, at 11:20 a.m. ET.</div><div>The NASDAQ London Investor Conference in London, U.K. The presentation is scheduled for Tuesday, December 8, 2026, at 1:00 p.m. GMT.</div><div><br></div><div>The presentations will be webcast live and replays will be available for a limited time, under the "Events and Presentations" section on the company&#039;s investor relations website at investors.octave.com.</div><div><br></div><div>FOR MORE INFORMATION, CONTACT:&nbsp;&nbsp;</div><div>Investors: Elizabeth Chwalk, VP, Investor Relations, investors@octave.com</div><div>Media: media@octave.com</div><div><br></div><div>About Octave</div><div><br></div><div>Octave provides mission-critical software that empowers organizations to make informed decisions across every stage of the asset lifecycle - Design, Build, Operate and Protect - where performance, safety and reliability are non-negotiable, and failure is not an option.</div><div><br></div><div>Turning complex operational data into actionable intelligence, Octave connects expertise, real-world conditions and enterprise-scale insight to improve performance, resilience and incident response where it matters most.</div><div><br></div><div>Octave has approximately 7,200 employees in 45 countries. Learn more at octave.com and follow us on LinkedIn.</div><div><br></div><div>Copyright 2026 GlobeNewswire, Inc.</div>   ]]></description>
<pubDate>Tue, 17 Nov 2026 07:08:00 +0700</pubDate>
</item>
<item>
<title>Infoblox Launches Australia Realm on AWS, Giving Regulated Organizations a Local Option for DDI Management and Preemptive Security</title>
<link>https://relleaseid.com/berita-bisnis/Infoblox-Launches-Australia-Realm-on-AWS--Giving-Regulated-Organizations-a-Local-Option-for-DDI-Management-and-Preemptive-Security</link>
<description><![CDATA[<img src=https://relleaseid.com/photo/berita/dir112026/3457_Infoblox-Launches-Australia-Realm-on-AWS--Giving-Regulated-Organizations-a-Local-Option-for-DDI-Management-and-Preemptive-Security.jpg border=0 hspace=5 align=left width=350 /><div><br></div><div>New regional deployment of the Infoblox Platform in the AWS Asia Pacific (Sydney) Region helps Australian agencies and enterprises manage and secure critical network infrastructure</div><div><br></div><div>SYDNEY, Nov. 16, 2026 (GLOBE NEWSWIRE) -- Infoblox, a leading platform for preemptive security and critical network services, today announced the launch of its new Australia realm: an instance of the Infoblox Platform hosted on Amazon Web Services (AWS) in the AWS Asia Pacific (Sydney) Region. This realm adds a regional deployment option for Australian organizations.</div><div><br></div><div>The new realm comes amid two connected pressures Australian organizations are facing today: cybercriminals are using automation and AI to compress attack timelines from weeks to minutes, while data-residency requirements can limit which software-as-a-service (SaaS) platforms agencies and regulated industries can adopt. Australia&#039;s Scams Prevention Framework Act 2025 reflects a growing focus on preventing threats, not just detecting them.</div><div><br></div><div>"Regulated organizations across Australia are investing in new infrastructure and adopting AI at pace, and they need a platform that can scale with them," said Scott Morris, managing director for Australia and New Zealand at Infoblox. "Built on AWS and supported by our regional partners, the Australia realm gives these organizations a regional deployment option with a platform built for the agentic era, that brings together Infoblox&#039;s networking and security capabilities."</div><div><br></div><div>The Australia realm is the company&#039;s first in Asia Pacific, hosted on AWS in the AWS Asia Pacific (Sydney) Region. The realm gives government agencies and enterprises a single SaaS platform to manage DNS, DHCP and IP address management (DDI), gain visibility into network assets, preempt threats with Infoblox Threat Defense and store customer data in the AWS Asia Pacific (Sydney) Region.</div><div><br></div><div>Australian organizations can now adopt the Infoblox Platform locally and scale their critical infrastructure protection.</div><div><br></div><div>Infoblox Universal DDI and Infoblox Threat Defense are available now in the Australia realm with Infoblox IQ for DDI and Infoblox IQ for Threat Defense following soon. To learn more, read the blog and explore Infoblox in the AWS Marketplace.</div><div><br></div><div>About Infoblox</div><div><br></div><div>Infoblox is a leading platform for preemptive security and hybrid, multi-cloud networking that delivers enterprise resilience and agility. Trusted by over 6,000 customers, including the majority of Fortune 100 companies as well as emerging innovators, we seamlessly integrate, secure and automate critical network services so businesses can move fast without compromise. Visit Infoblox.com, or follow us on LinkedIn.</div><div><br></div><div>Copyright 2026 GlobeNewswire, Inc.</div>   ]]></description>
<pubDate>Tue, 17 Nov 2026 07:04:00 +0700</pubDate>
</item>
<item>
<title>Broad AI Adoption Could Boost Latin America and Caribbean GDP by 5.1% Over a Decade, IDB Report Finds</title>
<link>https://relleaseid.com/berita-bisnis/Broad-AI-Adoption-Could-Boost-Latin-America-and-Caribbean-GDP-by-5-1--Over-a-Decade--IDB-Report-Finds</link>
<description><![CDATA[<img src=https://relleaseid.com/photo/berita/dir112026/837_Broad-AI-Adoption-Could-Boost-Latin-America-and-Caribbean-GDP-by-5-1--Over-a-Decade--IDB-Report-Finds.jpg border=0 hspace=5 align=left width=350 /><div><br></div><div>Wages could increase 4.2% over the same period</div><div><br></div><div>WASHINGTON, Nov. 16, 2026 (GLOBE NEWSWIRE) -- Broad adoption of artificial intelligence could boost Latin America and the Caribbean&#039;s gross domestic product (GDP) by 5.1% over a decade, a new report by the Inter-American Development Bank (IDB) finds. Wages could also increase by 4.2% over the same period, but the analysis stresses the need for reforms to capture these gains.</div><div><br></div><div>"From Digitalization to Artificial Intelligence: Turning Promises into Productivity," the 2026 edition of the Development in the Americas (DIA) series, highlights the economic potential of AI for a region that has struggled with weak productivity growth for six decades.</div><div><br></div><div>Digital technologies are already improving business operations and public services, and AI adoption can expand these gains. However, these technologies are not "plug-and-play"; realizing their full value requires firms and governments to redesign processes, retrain staff, and adopt new management practices, according to the report.</div><div><br></div><div>Progress will be faster when institutions are strong, high-quality digital skills are available, digital data and infrastructure are abundant, and obstacles to innovation and the spread of technology in both the public and private sectors are removed. Labor mobility is critical to ensure that benefits are large and widely shared, the report says.</div><div><br></div><div>The findings were fundamental to September&#039;s meeting of the IDB Group-led Partnership for AI Adoption, which convenes governments from the region and leading technology companies, such as Google, Anthropic, Microsoft, and Nvidia, to advance a shared roadmap for broad and safe AI adoption and unlock its productivity potential across Latin America and the Caribbean.</div><div><br></div><div>"Artificial intelligence can become a powerful accelerator of development, but its benefits will not come automatically," said IDB Group President Ilan Goldfajn. "Through the Partnership for AI Adoption, the IDB Group is bringing together governments and leading technology companies to help Latin America and the Caribbean harness AI&#039;s potential to raise productivity and translate those gains into better jobs, better public services, and shared prosperity."</div><div><br></div><div>"This report provides one of the most comprehensive economic assessments of what digitalization and AI could mean for Latin America and the Caribbean, moving the discussion from potential to evidence," said Laura Alfaro Maykall, IDB chief economist and economic counselor. "In our research, we quantify how AI could affect productivity, growth, and wages across the region and identify the conditions for countries to capture those gains."</div><div><br></div><div>Additional findings of the report include:</div><div><br></div><div>The region is running behind developed economies in adoption: 35% of adults reported using generative AI in 2025-2026, compared with 43% in European OECD countries and 58% in the United States.</div><div><br></div><div>Only 26% of adults report having recently interacted with government digitally, compared with 70% in OECD countries.</div><div><br></div><div>Only 27% of adults report having recently made purchases online, compared with 66% in OECD countries.</div><div><br></div><div>While 63% of digitally engaged firms surveyed report using generative AI, 82% rely on off-the-shelf tools or light adaptations rather than solutions integrated into their operations.</div><div>To manage risks, the report calls for targeted training and enhanced income support for displaced workers. It also endorses education systems that promote adaptability, greater private and public investments in cybersecurity, including data privacy, and regulations that carefully weigh the costs and benefits to households.</div><div><br></div><div>Digitalization and AI are already showing measurable results. In Mexico, an AI-based app helped reduced users&#039; depression by 20%. In Costa Rica, an electronic single-window system increased export values by 46%. In S?o Paulo, Brazil, a digital health platform serves 3.4 million users and has delivered 2 million teleconsultations.</div><div><br></div><div>The report concludes that Latin America and the Caribbean has an opportunity to turn AI into a powerful engine for productivity and growth. By strengthening institutions, skills, data, and digital infrastructure, and helping governments and firms put AI to productive use at scale, the region can turn technological change into lasting development gains.</div><div><br></div><div>About the IDB&nbsp;</div><div>The Inter-American Development Bank (IDB), a member of the IDB Group, is devoted to improving lives across Latin America and the Caribbean. Founded in 1959, the Bank works with the region&#039;s public sector to design and enable impactful, innovative solutions for sustainable and inclusive development. Leveraging financing, technical expertise, and knowledge, it promotes growth and well-being in 26 countries. Visit our website: <a href="http://www.iadb.org/en.">www.iadb.org/en.</a></div><div><br></div><div>Copyright 2026 GlobeNewswire, Inc.</div>   ]]></description>
<pubDate>Tue, 17 Nov 2026 06:59:00 +0700</pubDate>
</item>
<item>
<title>EAACI calls for allergy and respiratory health to be part of climate action at COP31</title>
<link>https://relleaseid.com/berita-bisnis/EAACI-calls-for-allergy-and-respiratory-health-to-be-part-of-climate-action-at-COP31</link>
<description><![CDATA[<img src=https://relleaseid.com/photo/berita/dir112026/6908_EAACI-calls-for-allergy-and-respiratory-health-to-be-part-of-climate-action-at-COP31.jpg border=0 hspace=5 align=left width=350 /><div><br></div><div>A dedicated symposium will connect scientific evidence, patient needs and climate policy, advancing EAACI&#039;s vision of a future free from the burden of allergy and asthma.</div><div><br></div><div>ZURICH, Switzerland, Nov. 16, 2026 (GLOBE NEWSWIRE) -- The European Academy of Allergy and Clinical Immunology (EAACI) will bring allergy and respiratory health into the dialogue at COP31, advocating for climate policies that better protect patients and address inequalities.</div><div><br></div><div>Longer pollen seasons, wildfires and air pollution highlight how closely environmental conditions and respiratory health are connected. For people living with allergic and respiratory diseases, climate action has implications for their everyday lives.</div><div><br></div><div>EAACI&#039;s participation reflects its commitment to Vision Zero: a future free from the burden of allergy and asthma. Achieving this ambition requires scientific progress and effective care, alongside prevention and policies that support healthier environments.</div><div><br></div><div>Through its symposium, "How the Implementation of the Paris Agreement Integrates Health Concerns - The Case of Allergic and Respiratory Diseases," EAACI will examine whether national climate commitments and adaptation plans adequately address this health burden.</div><div><br></div><div>The discussion will explore scientific evidence, identify gaps in policy and consider practical recommendations for integrating health into climate action. Particular attention will be given to inequalities in environmental exposure and access to care.</div><div><br></div><div>For EAACI, this dialogue is an opportunity to connect research with decisions that affect public health. Bringing allergy and respiratory expertise into climate discussions can help ensure that patients&#039; needs inform policy and that prevention becomes a shared priority across sectors.</div><div><br></div><div>The symposium will also invite stakeholder contributions, supporting continued dialogue between scientists, healthcare professionals, policymakers and communities.</div><div><br></div><div>Featuring Mohamed Shamji, Maria torres and Isabella Annesi-Maesano, alongside contributors from health and climate policy:</div><div><br></div><div>Date: Tuesday, 17 November 2026</div><div>Time: 11:30-12:30 Antalya time / 09:30-10:30 CET</div><div>Venue: Francophonie Pavilion, Antalya, T?rkiye</div><div>Language: French/English</div><div>Online: Live streaming via the event page</div><div><br></div><div>View the programme and access the live stream</div><div><br></div><div>About EAACI</div><div><br></div><div>EAACI advances allergy and clinical immunology through science, education, collaboration and advocacy, working to improve the lives of people affected by allergic and immunological diseases.</div><div><br></div><div>Media enquiries: communications@eaaci.org</div><div><br></div><div>Copyright 2026 GlobeNewswire, Inc.</div>   ]]></description>
<pubDate>Tue, 17 Nov 2026 06:53:00 +0700</pubDate>
</item>
<item>
<title>From beekeeping in the Azores to Tokyo&#039;s toilet tour: GetYourGuide reveals its 2027 Hidden Trends no algorithm can predict</title>
<link>https://relleaseid.com/berita-bisnis/From-beekeeping-in-the-Azores-to-Tokyo--039-s-toilet-tour--GetYourGuide-reveals-its-2027-Hidden-Trends-no-algorithm-can-predict</link>
<description><![CDATA[<img src=https://relleaseid.com/photo/berita/dir112026/5958_From-beekeeping-in-the-Azores-to-Tokyo--039-s-toilet-tour--GetYourGuide-reveals-its-2027-Hidden-Trends-no-algorithm-can-predict.jpg border=0 hspace=5 align=left width=350 /><div><br></div><div>BERLIN, NOVEMBER 16 2026 - Holidaymaxxing is out. Getting lost in the moment is in. In 2027, the best travel memories will come from a kimchi class in Seoul, a perfume lab in Florence, and a toilet tour in Tokyo.</div><div><br></div><div>That&#039;s the verdict from GetYourGuide, a leading global online marketplace to discover and book experiences worth traveling for. Their annual Hidden Trends report, based on millions of bookings and a survey of more than 10,000 travelers across seven countries, reveals that nearly 8 in 10 (78%) travelers say a truly restorative holiday means ditching the schedule.&nbsp;</div><div><br></div><div>Almost 1 in 3 leave the smartwatch at home. And yet this isn&#039;t anti-tech - more than half (56%) say digital planning before the trip is what lets them switch off during it.&nbsp; GetYourGuide calls it antioptimization: plan hard, then let go.</div><div><br></div><div>The shift is giving rise to five new traveler archetypes - the Scentualist, the Fermentor, the Detourist, the Player, the Pollinator - each named for the behavior that defines them. These are the hidden trends redefining how we travel in 2027:</div><div><br></div><div>The Scentualists: 69% of Gen Z would book a scent experience</div><div>In 2027, travelers won&#039;t just photograph a destination, they&#039;ll inhale it. Smell is the sense most tightly linked to memory, and a new generation is crossing continents in search of it. Over three-quarters (77%) of travelers say a single scent can instantly transport them back to a past holiday, and now they&#039;re actively booking around it. More than half (56%) are willing to pay for a dedicated scent experience, from a perfume masterclass, led by a perfumer in Florence, or a guided workshop in the French riviera, rising to 69% among Gen Z and 65% among older millennials. GetYourGuide booking data tells the same story: scent-related experiences have surged 114% year on year.</div><div><br></div><div>The Fermentors: 72% of travelers are fascinated by watching food made from scratch</div><div>Patience is a new luxury and travelers want to slow down and watch the magic happen. From crafting their own Kombucha with an expert instructor in Barcelona or a kimchi cookery class in Seoul using the instructor&#039;s family recipe. Nearly three-quarters (72%) say they&#039;re fascinated by watching food made from scratch, and 71% agree that understanding food origins adds deeper value to their travel. Among older millennials, 58% have chosen a destination specifically because of its food production. The booking data tells the same story. According to GetYourGuide data, balsamic and vinegar production experiences grew 73% year on year, wine and vineyard experiences rose 38%, and brewery experiences climbed 25%.</div><div><br></div><div>"Travelers come to learn kimchi from scratch, the way my mother taught me - and that matters, because younger generations in Korea aren&#039;t making it at home anymore. We&#039;re in this rapid moment of kimchi fading from family kitchens, so someone needs to inherit and keep the culture alive. We all live busy lives, so I share time-saving tips along the way, because I want everyone to try this at home."- Sam Lee, kimchi cookery class instructor in Seoul.</div><div><br></div><div>The Detourists: 61% of travelers deliberately seek out lesser-known neighborhoods</div><div>Head to the world&#039;s most famous destinations - and then do things nobody has heard of or see a city through a whole new lens. That&#039;s what detourists are all about. Whether it&#039;s a toilet tour in Tokyo,&nbsp; inspired by the Wim Wenders film Perfect Days, or seeing Rome through the eyes of Lizzie McGuire on a guided Vespa ride. More than 6 in 10 travelers (61%) say they&#039;re more likely to deliberately seek out lesser-known local neighborhoods compared to five years ago - rising to 72% among Gen Z and 69% among older millennials. The appetite for curated serendipity is growing: travelers don&#039;t want to skip the destination, they want to see it differently.</div><div><br></div><div>The Players: Gen Z wants to put down the controller and pick up petanque</div><div>In 2027, the generation raised on online gaming will travel the world to learn games they can&#039;t download. Nearly two-thirds (62%) of travelers would consider learning a local game while on holiday, from learning p?tanque with a local in Provence, to the basics of Schafkopf with a guide in Bavaria or traditional Japanese board games in Osaka. Among Gen Z, that willingness jumps to 78%, suggesting that a generation defined by digital play is keen to connect with local cultures by seeking out the analog version.</div><div><br></div><div>"Schafkopf is an integral part of Bavarian pub culture. Playing the game, we want to give travelers a personal connection to Bavaria and Munich and create a lasting memory with fun and shared experiences. The most important thing is Bavarian Gem?tlichkeit: a warm and relaxed sense of togetherness." - Bernd Roeren, manager of&nbsp; Bavaroona Tours, host of a Schafkopf experience in Bavaria, Germany.</div><div><br></div><div>The Pollinators: Beekeeping booking up 65% YoY</div><div>It&#039;s not just David Beckham taking up beekeeping - in 2027, travelers will swarm to this hobby that fosters patience and the ability to slow down. GetYourGuide booking data shows beekeeping experiences have surged 65% year on year, from the burrowing bees of Yinggarda Country, Australia, to beekeeping, led by a local apiarist in the Azores. Half of all travelers surveyed (50%) said they&#039;d consider a beekeeping experience, signaling that pollinator tourism is moving from niche curiosity to mainstream trend</div><div><br></div><div>"Bees have a lot to teach us, because they live in a real community. One bee is not important: they work together as one organism. When you feel the honey, when you taste the honey, you can get a sense of the landscape where the bees are. The honey is a fingerprint of the Azorean landscape." - Carolina Ferraz, beekeeping experience guide in the Azores.</div><div><br></div><div>What the experts say</div><div><br></div><div>"Travelers aren&#039;t planning less, they&#039;re planning differently. Eight in 10 want a holiday free from a schedule, so instead of cramming in a must-see list, they&#039;re choosing a few experiences to go deep on, from keeping bees in the Azores to crafting a perfume in Florence. Our Hidden Trends points to a shift away from optimization culture to a deeper and more meaningful travel experience." - Anne Wallin, GetYourGuide&#039;s Global Trends and Experiences expert</div><div><br></div><div>"I&#039;m a big believer in planning ahead, but in a way that leaves room to be spontaneous. That&#039;s the kind of travel GetYourGuide was built for, and why I love the rise of &#039Detourists&#039;: people who visit well-known destinations but see them through a completely different lens. It&#039;s about booking what matters before you go, then staying open to a local tip that shows you a side of the city you&#039;d never have found on your own. It&#039;s the planned moment that gets you there, but the unexpected one that you remember." - Chelsea Dickenson, the Holiday Expert, Consumer Expert</div><div><br></div><div>About GetYourGuide</div><div>GetYourGuide is a leading global online marketplace to discover and book experiences worth traveling for. Travelers can use GetYourGuide to find things to do in more than 18,000 cities, including tours from local experts, exclusive access to must-see attractions, as well as immersive bucket-list experiences. More than 50,000 supply partners leverage GetYourGuide&#039;s easy-to-use platform to grow their businesses, offering 200,000 experiences to travelers around the world. For more information, follow GetYourGuide on LinkedIn, Instagram and TikTok and visit getyourguide.com.</div><div><br></div><div>About Sam Lee</div><div>Sam is a Seoul-based guide and certified traditional liquor producer who specialises in Korean food culture and fermented beverages. He runs a kimchi workshop rooted in his family&#039;s recipes and hosts traditional soju tastings at a craft distillery, drawing on around a decade of study in Korean brewing and distillation. His work has been featured in Tatler Asia.</div><div><br></div><div>About the data</div><div>GetYourGuide&#039;s survey was conducted online by Bounce Insights, a leading agile research platform, across 7 markets (US, UK, France, Spain, Italy, Germany, Japan). n = 10,157 respondents.</div><div><br></div><div>GetYourGuide 2027 Hidden Trends: FAQ</div><div><br></div><div>What is GetYourGuide&#039;s 2027 Hidden Trends report?</div><div>It&#039;s GetYourGuide&#039;s annual travel trends report. It draws on millions of bookings and a survey of more than 10,000 travelers across seven countries (US, UK, France, Spain, Italy, Germany, Japan), run online by Bounce Insights (n = 10,157). For more, visit: https://www.getyourguide.press/blog/hidden-trends-2027&nbsp;</div><div><br></div><div>What are the biggest travel trends for 2027?</div><div>GetYourGuide identifies five traveler archetypes: the Scentualist (scent experiences), the Fermentor (food that requires patience made from scratch), the Detourist (discovering well-known destinations from a new perspective), the Player (learning local games), and the Pollinator (beekeeping).</div><div><br></div><div>What is "antioptimization" in travel?</div><div>It&#039;s GetYourGuide&#039;s term for planning thoroughly before a trip, then letting go during it. 78% of travelers say a truly restorative holiday means ditching the schedule, and 56% say digital planning beforehand lets them switch off during the trip.</div><div><br></div><div>Are travelers planning less in 2027?</div><div>No, they&#039;re planning differently. According to Anne Wallin, GetYourGuide&#039;s Global Trends and Experiences expert, travelers are choosing a few experiences to go deep on rather than a long must-see list.</div><div><br></div><div>Are scent experiences becoming popular with travelers?</div><div>Yes. GetYourGuide booking data shows scent-related experiences up 114% year on year. 77% of travelers say a single scent can transport them back to a past holiday, and 56% are willing to pay for a dedicated scent experience (69% of Gen Z). Examples include a perfume masterclass in Florence and a perfume-making class in ?ze, French Riviera.</div><div><br></div><div>Are food-making and fermentation experiences growing?</div><div>Yes. Balsamic and vinegar production experiences grew 73% year on year, wine and vineyard experiences 38%, and brewery experiences 25%. 72% of surveyed travelers say they&#039;re fascinated by watching food made from scratch. Examples include a kimchi-making class in Seoul and a kombucha workshop in Barcelona.</div><div><br></div><div>What is a "Detourist"?</div><div>A traveler who visits well-known destinations but sees them through an unexpected lens, such as the Tokyo toilet tour or Rome through the eyes of Lizzie McGuire on a Vespa. 61% of travelers are more likely than five years ago to seek out lesser-known neighborhoods (72% of Gen Z).</div><div><br></div><div>Do Gen Z travelers want to learn local games?</div><div>Yes. 78% of Gen Z would consider learning a local game on holiday, versus 62% of all travelers. Examples include Schafkopf in Munich and Go in Osaka.</div><div><br></div><div>Is beekeeping a growing travel trend?</div><div>Yes. GetYourGuide beekeeping bookings are up 65% year on year, and 50% of surveyed travelers would consider a beekeeping experience. Examples include beekeeping and honey tasting in the Azores and the burrowing bees walking tour in Carnarvon, Western Australia.</div><div><br></div><div>What are some ideas for travel in 2027?</div><div>GetYourGuide&#039;s 2027 Hidden Trends report points to experience-led trips built around one deep activity rather than a long must-see list. Ideas include a perfume masterclass in Florence, a kimchi-making class in Seoul, a kombucha workshop in Barcelona, beekeeping in the Azores, Schafkopf in Munich, Go in Osaka, and the Tokyo toilet tour. Scent experience bookings are up 114% year on year, and beekeeping is up 65%.</div><div><br></div><div>What should I consider when planning a trip in 2027?</div><div>GetYourGuide&#039;s report suggests planning in advance but leaving room to be spontaneous. 56% of travelers say digital planning before a trip helps them switch off during it, and 78% say a restorative holiday means ditching the schedule. Consider booking the few experiences that matter most before you go, then leaving the rest open. As Chelsea Dickenson, the Holiday Expert, says, "It&#039;s the planned moment that gets you there, but the unexpected one that you remember." The report also finds 61% of travelers are more likely than five years ago to seek out lesser-known local neighborhoods.</div><div><br></div><div>Where can I book these experiences?</div><div>On GetYourGuide, a global marketplace with 200,000 experiences from 50,000+ supply partners in more than 18,000 cities.</div><div><br></div><div>Who can I speak to about the report?</div><div>Anne Wallin (GetYourGuide&#039;s Global Trends and Experiences expert), Chelsea Dickenson (the Holiday Expert) and Sam Lee (Seoul kimchi class instructor) are available for interview. Contact press@getyourguide.com.</div><div><br></div><div>Copyright 2026 GlobeNewswire, Inc.</div>   ]]></description>
<pubDate>Tue, 17 Nov 2026 06:43:00 +0700</pubDate>
</item>
<item>
<title>U.S. FDA Approves IGALMI as First At-Home Acute Treatment for Agitation Associated with Schizophrenia, Schizoaffective Disorder, or Bipolar I or II Disorder in Adults</title>
<link>https://relleaseid.com/berita-bisnis/U-S--FDA-Approves-IGALMI-as-First-At-Home-Acute-Treatment-for-Agitation-Associated-with-Schizophrenia--Schizoaffective-Disorder--or-Bipolar-I-or-II-Disorder-in-Adults</link>
<description><![CDATA[<img src=https://relleaseid.com/photo/berita/dir112026/3779_U-S--FDA-Approves-IGALMI-as-First-At-Home-Acute-Treatment-for-Agitation-Associated-with-Schizophrenia--Schizoaffective-Disorder--or-Bipolar-I-or-II-Disorder-in-Adults.jpg border=0 hspace=5 align=left width=350 /><div><br></div><div>*First at-home treatment provides a new option for patients and caregivers to address agitation outside of a healthcare setting</div><div>*Approval is supported by results of the Phase 3 SERENITY Trial, in which IGALMI met its primary endpoint of safety and tolerability in the at-home setting1</div><div>*Milestone supports Teva&#039;s Pivot to Growth strategy and adds to company&#039;s commitment to patient-centered innovation in neuroscience</div><div><br></div><div>PARSIPPANY, N.J., Nov. 16, 2026 (GLOBE NEWSWIRE) -- Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), today announced the U.S. Food and Drug Administration (FDA) approval of IGALMI (dexmedetomidine) sublingual film for at-home use. With this approval, IGALMI becomes the first FDA-approved treatment that can be used at home for agitation associated with schizophrenia, schizoaffective disorder, or bipolar I or II disorder in adults.</div><div><br></div><div>"For people living with schizophrenia, schizoaffective disorder, or bipolar disorder, agitation can be disruptive and challenging for themselves and for the caregivers who support them," said Chris Fox, Executive Vice President, U.S. Commercial and Head of Innovative Franchise at Teva. "With the first FDA-approved, at-home treatment for agitation associated with these conditions, we have an opportunity to bring an important treatment option into a setting where patients often need it, reflecting Teva&#039;s commitment to improving how care is experienced in everyday life."</div><div><br></div><div>Agitation associated with schizophrenia, schizoaffective disorder, or bipolar I or II disorder affects between 25% and 40% of patients across these conditions.2 Acute agitation can escalate quickly, creating significant challenges for patients, families and caregivers and, in up to 21% of cases, can result in an emergency department visit or hospitalization.3</div><div><br></div><div>"Innovation in neuroscience is about discovering new medicines and also about rethinking when, where and how treatment can be delivered," said Eric Hughes, M.D., Ph.D., Executive Vice President, Global R&D and Chief Medical Officer at Teva. "The ability to treat agitation symptoms when they start gives patients and caregivers an important new way to manage these episodes."</div><div><br></div><div>In the Phase 3 SERENITY At-Home Safety and Tolerability Trial, 1,160 agitation episodes in 102 patients were treated with IGALMI, and tolerability remained consistent with repeat dosing over the 12-week study period.1,4 The most commonly reported adverse events (&#8805;5% and greater than placebo) were somnolence, dry mouth, dizziness, and oral paresthesia or oral hypoesthesia. In the Phase 3 SERENITY At-Home Trial, there were no discontinuations due to tolerability with IGALMI treatment.1 Please refer to the Important Safety Information below for additional safety information.</div><div><br></div><div>Teva acquired IGALMI in late October 2026. The application for the approval of IGALMI for at-home use was submitted on January 14, 2026, as a supplemental New Drug Application (sNDA) to the IGALMI NDA for use under the supervision of a healthcare provider. Teva will announce commercialization plans for IGALMI for at-home use at a later date.</div><div><br></div><div>About IGALMI (dexmedetomidine) Sublingual Film</div><div><br></div><div>IMPORTANT SAFETY INFORMATION&nbsp;&nbsp;</div><div><br></div><div>WHAT IS IGALMI?&nbsp;</div><div><br></div><div>IGALMI (dexmedetomidine) sublingual film is a prescription medicine that is placed under your tongue or between your lower lip and gum and is used for the treatment of sudden (acute) agitation in adults with schizophrenia, schizoaffective disorder or bipolar disorder I or II in adults. It is not known if IGALMI is safe and effective in children.&nbsp;</div><div><br></div><div>IGALMI can cause serious side effects, including:&nbsp;</div><div><br></div><div>Low blood pressure, low blood pressure when standing after sitting or lying and slow heart rate. You should drink fluids and sit or lie down after taking IGALMI. Get up slowly after taking IGALMI to help prevent your risk of fainting or falling.&nbsp; &nbsp;</div><div>The most common side effects of IGALMI in the healthcare supervised setting include sleepiness or drowsiness, numbness or tingling in the mouth, dizziness, dry mouth, low blood pressure, and low blood pressure when standing after sitting or lying down.&nbsp;</div><div><br></div><div>The most common side effects of IGALMI in the unsupervised setting include sleepiness or drowsiness, dry mouth, dizziness and numbing or tingling in the mouth.&nbsp; &nbsp;</div><div><br></div><div>These are not all the possible side effects of IGALMI. Call your doctor for medical advice about side effects.&nbsp;</div><div><br></div><div>Tell your healthcare provider about your medical history, including if you have heart problems, have a slow heart rate, have low blood pressure (hypotension), have long-term (chronic) high blood pressure, have a history of fainting, have low blood or fluid levels in your body (hypovolemia), have diabetes, have low blood potassium or magnesium levels, are 65 years of age or older, or have liver problems. Tell your healthcare provider if you are pregnant or breastfeeding.&nbsp; It is not known if IGALMI will harm your unborn baby.&nbsp; Talk to your healthcare provider about the best way to feed your baby during treatment with IGALMI.&nbsp; &nbsp;</div><div><br></div><div>Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. Especially tell your healthcare provider if you take blood pressure medicines, medicines for heart problems or medicines that make you sleepy, such as sleeping or pain (opioids) medicines.&nbsp; Do not start any new medicine during treatment with IGALMI without talking to your healthcare provider first.&nbsp;&nbsp;</div><div><br></div><div>IGALMI Clinical Program Overview</div><div>IGALMI is a proprietary sublingual film formulation of dexmedetomidine, a highly selective &#945;2-adrenergic receptor agonist, approved for the acute treatment of agitation associated with schizophrenia, schizoaffective disorder, or bipolar I or II disorder in adult patients for self-administration at home or under healthcare provider supervision in a healthcare setting.1 The pivotal SERENITY I/II Phase 3 trials for the healthcare supervised setting use of IGALMI were randomized, double-blind, placebo-controlled, fixed-dose studies evaluating sublingual doses of dexmedetomidine in adults with agitation associated with schizophrenia, schizoaffective disorder, or bipolar I or II disorders. </div><div><br></div><div>The studies met their primary endpoint, demonstrating statistically significant reductions in agitation versus placebo, as assessed by the Positive and Negative Syndrome Scale-Excited Component (PEC) score, with treatment effects observed as early as 20 minutes after some dosing studied in the neuropsychiatric disorders. Across the pivotal SERENITY I/II Phase 3 studies, treatment with IGALMI resulted in an average reduction of ~9.6 points in PEC total score at 2 hours following administration, compared with reductions of ~4.9 points with placebo in patients with schizophrenia, schizoaffective disorder, or bipolar I or II disorder.1</div><div><br></div><div>The Phase 3 SERENITY At-Home trial was a randomized, double-blind, placebo-controlled, 12-week Phase 3 study of self-administered IGALMI outside of a healthcare setting. The study evaluated IGALMI for the treatment of agitation episodes in adults with schizophrenia, schizoaffective disorder, or bipolar I or II disorders outside of a supervised healthcare setting.5 The most commonly reported adverse events (&#8805;5% and greater than placebo) were somnolence, dry mouth, dizziness, and oral paresthesia or oral hypoesthesia consistent with the known pharmacology of IGALMI used in a healthcare supervised setting.1</div><div><br></div><div>About Agitation in Schizophrenia, Schizoaffective Disorder, or Bipolar I or II Disorder</div><div>Agitation is a distressing and disruptive symptom associated with schizophrenia, schizoaffective disorder, or bipolar I or II disorder that may include feelings of tension, restlessness, and increased activity. Agitation can occur across a variety of settings, including at home and in the community and affects 25-40% of people with these conditions.2&nbsp; Episodes can escalate in severity and, in up to 21% of cases, require emergency medical care.3&nbsp; Until now, with the approval of IGALMI for at-home use, there were no FDA-approved treatments specifically indicated for patient self-administration at home during an agitation episode. Existing treatment options generally require administration in a healthcare setting or under the supervision of a healthcare provider, highlighting an important unmet need for treatment options that can be used where episodes occur.</div><div><br></div><div>IGALMI (dexmedetomidine) Sublingual Film</div><div>IGALMI is a proprietary sublingual film formulation of dexmedetomidine, a highly selective &#945;2-adrenergic receptor agonist, approved for the acute treatment of agitation associated with schizophrenia, schizoaffective disorder, or bipolar I or II disorder in adult patients for self-administration at home or under healthcare provider supervision in a healthcare setting.1</div><div><br></div><div>About Teva&nbsp;</div><div>Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) is a global biopharmaceutical company, enabled by a world-class generics business. For over 120 years, Teva&#039;s commitment to bettering health has never wavered. From innovating in the fields of neuroscience and immunology to providing complex generic medicines, biosimilars and pharmacy brands worldwide, Teva is dedicated to addressing patients&#039; needs, now and in the future. At Teva, We Are All In For Better Health. To learn more about how, visit www.tevapharm.com.&nbsp;</div><div><br></div><div>Teva Cautionary Note Regarding Forward-Looking Statements&nbsp;</div><div>This Press Release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, which are based on management&#039;s current beliefs and expectations and are subject to substantial risks and uncertainties, both known and unknown, that could cause our future results, performance or achievements to differ significantly from that expressed or implied by such forward-looking statements. You can identify these forward-looking statements by the use of words such as "should," "expect," "anticipate," "estimate," "target," "may," "project," "intend," "plan," "believe" and other words and terms of similar meaning and expression in connection with any discussion of future operating or financial performance. Important factors that could cause or contribute to such differences include risks relating to: our ability to successfully commercialize IGALMI for the at-home treatment of agitation associated with schizophrenia, schizoaffective disorder, or bipolar I or II disorder in adults; our ability to successfully compete in the marketplace, including our ability to develop and commercialize additional pharmaceutical products; our ability to successfully execute on our Pivot to Growth strategy, including to expand our innovative and biosimilar medicines pipeline and to profitably commercialize our innovative medicines and biosimilar portfolio, whether organically or through business development; our significant indebtedness; our business and operations in general; compliance, regulatory and litigation matters; financial, economic and other risks; and other factors discussed in our Quarterly Report on Form 10-Q for the third quarter of 2026 and in our Annual Report on Form 10-K for the year ended December 31, 2025, including in the sections captioned "Risk Factors" and "Forward-looking Statements." Forward-looking statements speak only as of the date on which they are made, and we assume no obligation to update or revise any forward-looking statements or other information contained herein, whether as a result of new information, future events or otherwise. You are cautioned not to put undue reliance on these forward-looking statements.</div><div><br></div><div>References:</div><div><br></div><div>IGALMI (dexmedetomidine) sublingual film, for sublingual or buccal use. Prescribing information. Teva Neuroscience, Inc; [2026].</div><div>Data on file. [Trinity Partners Research]. Parsippany, NJ: Teva Neuroscience, Inc.</div><div>Hokett S, Benjumea D, Rava A, Wassel CL, Callahan P, Benabou R. PMH23 epidemiology of acute agitation secondary to schizophrenia and/or bipolar disorder in patients presenting to emergency departments, a systematic literature review. Value Health. 2021;24(suppl 1):S132. doi:10.1016/j.jval.2021.04.645</div><div>Citrome L, Rajachandran L, Risinger R, et al. BXCL501 (sublingual dexmedetomidine) for treatment of agitation associated with bipolar disorder or schizophrenia in the home setting: a phase 3 study. [Study poster]. 2025. Accessed November 9, 2026. https://www.sec.gov/Archives/edgar/data/1720893/000110465925108840/tm2530721d1_ex99-1.htm</div><div>Dexmedetomidine in the treatment of agitation associated with schizophrenia and bipolar disorder (SERENITY III). ClinicalTrials.gov identifier: NCT05658510. Updated July 30, 2025. Accessed November 4, 2026. https://clinicaltrials.gov/study/NCT05658510</div><div><br></div><div>Copyright 2026 GlobeNewswire, Inc.</div>   ]]></description>
<pubDate>Tue, 17 Nov 2026 06:36:00 +0700</pubDate>
</item>
<item>
<title>Bitget Launches rToken Earn, Bringing Onchain Yield to Tokenized ETFs with Bitwise Set to Curate the Strategy</title>
<link>https://relleaseid.com/berita-bisnis/Bitget-Launches-rToken-Earn--Bringing-Onchain-Yield-to-Tokenized-ETFs-with-Bitwise-Set-to-Curate-the-Strategy</link>
<description><![CDATA[<img src=https://relleaseid.com/photo/berita/dir112026/6859_Bitget-Launches-rToken-Earn--Bringing-Onchain-Yield-to-Tokenized-ETFs-with-Bitwise-Set-to-Curate-the-Strategy.jpg border=0 hspace=5 align=left width=350 /><div><br></div><div>VICTORIA, Seychelles, Nov. 16, 2026 (GLOBE NEWSWIRE) -- Bitget, the world&#039;s largest Universal Exchange (UEX), has launched rToken Earn, enabling eligible non-U.S. users in permitted jurisdictions to earn variable onchain yield on rQQQ and rSPY, while maintaining exposure to the underlying ETFs. The product is accessible through Bitget Earn, without requiring a separate wallet or direct interaction with DeFi protocols.</div><div><br></div><div>rToken Earn extends the use of Reality-issued rTokens beyond trading and collateral. Users can subscribe to vaults for rSPY and rQQQ through their existing Bitget account. Bitget handles subscriptions and redemptions on their behalf, with no fixed subscription term.</div><div><br></div><div>Bitwise Investment Manager, LLC, a wholly owned subsidiary of Bitwise Asset Management, is set to curate the vault strategy. Ember Protocol will provide the underlying vault infrastructure, while Fluid will supply the lending markets and liquidity used by the strategy. Underpinning it all will be rTokens themselves, issued by Reality and backed 1:1 by the corresponding securities. Yields are variable and not guaranteed.</div><div><br></div><div>"An asset should not be limited to just one purpose," said Gracy Chen, CEO of Bitget. "With rToken Earn, users can maintain their exposure to ETFs like the S&P 500 and Nasdaq-100 trackers while accessing onchain yield through the same Bitget account. With Universal Exchange, we aim to give users more ways to put their assets to work without moving between platforms."</div><div><br></div><div>The launch follows further expansion of Bitget&#039;s tokenized equities offering in 2026. DeFiLlama Research recorded more than $1.86 billion in cumulative rToken trading volume between June and July. In October, Bitget introduced rToken Stock Transfer, enabling eligible users to convert supported brokerage holdings into rTokens through a two-step process.</div><div><br></div><div>"Tokenizing equities is the first step towards onchain finance. Putting them to work comes next," said Jonathan Man, Portfolio Manager, Head of Multi-Strategy Solutions & DeFi Strategies, Bitwise. "We&#039;re set to curate a strategy that connects tokenized ETF exposure with onchain lending opportunities."</div><div><br></div><div>"The best financial infrastructure is the kind users never have to think about," said Ibra Barbery, Co-Founder, Ember. "Ember was built so that asset managers can run professional strategies onchain with the controls and security that it requires, and so that platforms like Bitget can offer those strategies through an experience their users already know. Seeing tokenized ETFs move onto that infrastructure is a clear sign of where onchain wealth management is heading."</div><div><br></div><div>"Lending has always been one of the engines of capital markets, and onchain it can run with full transparency," said Samyak Jain, Founder and CEO, Fluid. "Bringing tokenized ETFs into Fluid extends our liquidity layer to some of the most widely held assets in traditional finance, and shows what becomes possible when real-world assets and DeFi share the same infrastructure."</div><div><br></div><div>rToken Earn is available from today to eligible non-U.S. users, starting with rQQQ and rSPY. Yields are variable and not guaranteed, and availability depends on jurisdiction and eligibility. The strategy curation service from Bitwise is not available at launch and will roll out at a later date.</div><div><br></div><div>About Bitget</div><div>Bitget is the world&#039;s largest Universal Exchange (UEX), serving over 125 million users and offering access to over 2M crypto tokens, 500+ tokenized stocks, ETFs, commodities, FX, and precious metals such as gold. The ecosystem is committed to helping users trade smarter with its AI agent, which co-pilots trade execution. Bitget is driving crypto adoption through strategic partnerships such as MotoGP. Bitget currently leads in the tokenized TradFi market, providing the industry&#039;s lowest fees and highest liquidity across 150 regions worldwide.</div><div><br></div><div>About Reality</div><div>Reality is a regulated real-world asset issuance platform built for global markets, and is proudly part of the Bitget ecosystem. Working with licensed brokers across major exchanges, including Nasdaq and the NYSE, we purchase and hold the underlying assets in custody, then issue the corresponding rights on-chain. This connects traditional capital markets with on-chain infrastructure, opening institutional-grade access to real-world assets for users worldwide.</div><div><br></div><div>About Bitwise</div><div>Bitwise Asset Management is a global crypto asset manager with more than $14 billion in client assets. It manages a suite of over 70 investment products in the U.S. and Europe, spanning ETPs, index funds, alpha and SMA strategies, vaults, and staking solutions. Bitwise Investment Manager, LLC ("BIM"), a wholly owned subsidiary of Bitwise Asset Management, provides strategy curation services to vaults. BIM is an investment adviser registered with the U.S. Securities and Exchange Commission, a commodity pool operator and commodity trading advisor registered with the Commodity Futures Trading Commission, and a member of the National Futures Association.</div><div><br></div><div>About Ember</div><div>Ember is a decentralized vaults infrastructure protocol that unifies cross-chain yield strategies, structured products, and tokenized assets into one platform, making liquidity accessible, transparent, and trustless. It is building the foundation and infrastructure to democratize wealth management.</div><div><br></div><div>About Fluid</div><div>Fluid is an onchain liquidity layer that combines lending, borrowing and trading in a single system. Fluid holds $4B+ in deposits and has processed $240B+ in trading volume since launch. It powers Jupiter Lend, the largest lending market on Solana, and is live across Ethereum, Arbitrum, Base, Polygon, Plasma and Solana.</div><div><br></div><div>About Tether</div><div>Tether is a pioneer in the field of stablecoin technology, driven by an aim to revolutionize the global financial landscape. With a mission to provide accessible and efficient financial, communication, artificial intelligence, and energy infrastructure. Tether enables greater financial inclusion, and communication resilience, fosters economic growth, and empowers individuals and businesses alike. As the creator of the largest, most transparent, and liquid stablecoin in the industry, Tether is dedicated to building sustainable and resilient infrastructure for the benefit of underserved communities. </div><div><br></div><div>By leveraging cutting-edge blockchain and peer-to-peer technology, it is committed to bridging the gap between traditional financial systems and the potential of decentralized finance.</div><div><br></div><div>Risk Warning: Digital asset prices are subject to fluctuation and may experience significant volatility. Investors are advised to only allocate funds they can afford to lose. The value of any investment may be impacted, and there is a possibility that financial objectives may not be met, nor the principal investment recovered. </div><div><br></div><div>Independent financial advice should always be sought, and personal financial experience and standing carefully considered. Past performance is not a reliable indicator of future results. Bitget accepts no liability for any potential losses incurred. Nothing contained herein should be construed as financial advice. For further information, please refer to our Terms of Use.</div><div><br></div><div>Bitwise Disclosures</div><div><br></div><div>No Offer; Access Restrictions. Nothing on this page constitutes an offer to sell, or a solicitation of an offer to buy, any security or financial instrument in any jurisdiction. This page is for informational purposes only and does not constitute investment, financial, legal, or tax advice. rQQQ and rSPY have not been registered under the Securities Act of 1933 and may not be offered or sold in the United States or to U.S. Persons. </div><div><br></div><div>Prospective depositors should consult their own professional advisers before depositing. This vault is available only to non-U.S. Persons as defined in Rule 902(k) of Regulation S under the Securities Act of 1933. Geofencing and access controls are implemented by Ember Protocol. </div><div><br></div><div>By depositing, you represent that you are not a U.S. Person, are not acting for the account or benefit of a U.S. Person, are not in a sanctioned jurisdiction, and acknowledge that rQQQ and rSPY have not been registered under the Securities Act. No transfer restrictions are enforced at the smart-contract level; you are responsible for continued compliance. Breach of eligibility representations triggers the indemnification obligations in the Bitwise Onchain Terms of Use.</div><div><br></div><div>Copyright 2026 GlobeNewswire, Inc.</div>   ]]></description>
<pubDate>Tue, 17 Nov 2026 06:31:00 +0700</pubDate>
</item>
<item>
<title>YYForce Sets Operating Priorities Across AI Workforce, Robotics and Facility Management</title>
<link>https://relleaseid.com/berita-bisnis/YYForce-Sets-Operating-Priorities-Across-AI-Workforce--Robotics-and-Facility-Management</link>
<description><![CDATA[<img src=https://relleaseid.com/photo/berita/dir112026/3193_YYForce-Sets-Operating-Priorities-Across-AI-Workforce--Robotics-and-Facility-Management.jpg border=0 hspace=5 align=left width=350 /><div><br></div><div>Company Targets Commercial Robotics Scaling, Humanoid R&D and Disciplined Cash Generation</div><div><br></div><div>SINGAPORE, Nov. 16, 2026 (GLOBE NEWSWIRE) -- YYForce Inc. (NASDAQ: YFOR) ("YYForce" or the "Company"), an AI-enabled frontline workforce, robotics, and facility solutions provider, today outlined its operating priorities across frontline staffing, integrated facility management and commercial robotics.</div><div><br></div><div>YYForce is focused on improving staffing and service delivery, using its software platforms to simplify day-to-day operations, and evaluating service robot deployments based on reliability, customer needs and operating costs.</div><div><br></div><div>"Our customers need dependable staffing and reliable facility services," said Mike Fu, Chairman and Chief Executive Officer of YYForce. "We&#039;re focused on improving how we deliver those services and using AI and robotics where they can make a measurable difference for customers. We&#039;ll apply the same discipline to new deployments that we apply to managing costs and working capital."</div><div><br></div><div>Operating Priorities</div><div><br></div><div>Staffing and facility management. Improve workforce deployment, service quality and customer delivery across core operations.</div><div>Workforce and facility software. Use YY Circle and Yolara AI to support frontline workforce matching and coordination, and 24iFM to support digital estate management.</div><div>Commercial robotics. Expand service robot deployment and leasing in hospitality and facility settings, with attention to reliability, integration and deployment costs.</div><div>Humanoid robotics development. Develop capabilities for hospitality and facility tasks where humanoid robots could work alongside frontline teams.</div><div>Financial discipline. Manage operating costs and working capital, and evaluate investments based on expected operating performance and cash generation.</div><div>About YYForce Inc.</div><div><br></div><div>YYForce Inc. (NASDAQ: YFOR) is an AI-enabled workforce solutions and integrated facility management provider operating across Asia and beyond. Driven by its mission to transform frontline work through AI, robotics, and integrated workforce solutions, the Company brings together people, intelligent software, and commercial robotics into one connected ecosystem. Its portfolio spans intelligent workforce matching (YY Circle, Yolara AI), digital estate management (24iFM), and service robot deployment, leasing, maintenance, and humanoid robotics development-serving hospitality, facilities management, retail, logistics, and other frontline-driven industries. Guided by its vision to build the future of work where people and intelligent technology thrive together, YYForce helps businesses improve productivity, enhance everyday experiences, and build a smarter, more sustainable workforce. For more information, visit https://www.yyforce.ai.</div><div><br></div><div>Forward-Looking Statements</div><div><br></div><div>This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These statements include expectations regarding the Company&#039;s strategy, growth opportunities, technology development, robotics and humanoid applications, and operating objectives. Words such as "expects," "intends," "plans," "will," "may" and similar expressions identify forward-looking statements, although not all such statements contain these words.</div><div><br></div><div>These statements reflect current expectations and involve risks, uncertainties and assumptions. Actual results may differ materially because of customer demand, competition, financing availability, technology performance, deployment costs, execution risks and other factors described in the Company&#039;s filings with the U.S. Securities and Exchange Commission, including the "Risk Factors" section of its most recent annual report on Form 20-F, as amended. No assurance can be given that the Company will achieve its objectives. Except as required by law, the Company undertakes no obligation to update these statements.</div><div><br></div><div>Copyright 2026 GlobeNewswire, Inc.</div>   ]]></description>
<pubDate>Tue, 17 Nov 2026 06:22:00 +0700</pubDate>
</item></channel></rss>